database,exposure,outcomeCategory,Disease,denomPatid,denomIndexExp,timeWindow,numer,prevPct
MPCD,DMARD,Cancer,Hematologic Cancer,412,479,12 months,9,1.878914405
MPCD,DMARD,Cancer,Hematologic Cancer,412,479,24 months,9,1.878914405
MPCD,DMARD,Cancer,Hematologic Cancer,412,479,36 months,9,1.878914405
MPCD,DMARD,Cancer,Hematologic Cancer,412,479,AS cohort entry to exposure,7,1.4613778706
MPCD,DMARD,Cancer,Solid Cancer,412,479,12 months,20,4.1753653445
MPCD,DMARD,Cancer,Solid Cancer,412,479,24 months,25,5.2192066806
MPCD,DMARD,Cancer,Solid Cancer,412,479,36 months,25,5.2192066806
MPCD,DMARD,Cancer,Solid Cancer,412,479,AS cohort entry to exposure,13,2.7139874739
MPCD,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,412,479,12 months,11,2.2964509395
MPCD,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,412,479,24 months,12,2.5052192067
MPCD,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,412,479,36 months,12,2.5052192067
MPCD,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,412,479,AS cohort entry to exposure,6,1.2526096033
MPCD,DMARD,Cardiac disease,Conduction Block,412,479,12 months,4,0.8350730689
MPCD,DMARD,Cardiac disease,Conduction Block,412,479,24 months,4,0.8350730689
MPCD,DMARD,Cardiac disease,Conduction Block,412,479,36 months,4,0.8350730689
MPCD,DMARD,Cardiac disease,Conduction Block,412,479,AS cohort entry to exposure,3,0.6263048017
MPCD,DMARD,Cardiac disease,Myocardial infarction,412,479,12 months,0,0
MPCD,DMARD,Cardiac disease,Myocardial infarction,412,479,24 months,0,0
MPCD,DMARD,Cardiac disease,Myocardial infarction,412,479,36 months,0,0
MPCD,DMARD,Cardiac disease,Myocardial infarction,412,479,AS cohort entry to exposure,1,0.2087682672
MPCD,DMARD,Infection,Hospitalized infection,412,479,12 months,2,0.4175365344
MPCD,DMARD,Infection,Hospitalized infection,412,479,24 months,6,1.2526096033
MPCD,DMARD,Infection,Hospitalized infection,412,479,36 months,11,2.2964509395
MPCD,DMARD,Infection,Hospitalized infection,412,479,AS cohort entry to exposure,2,0.4175365344
MPCD,DMARD,Infection,Opportunistic infection,412,479,12 months,11,2.2964509395
MPCD,DMARD,Infection,Opportunistic infection,412,479,24 months,14,2.9227557411
MPCD,DMARD,Infection,Opportunistic infection,412,479,36 months,17,3.5490605428
MPCD,DMARD,Infection,Opportunistic infection,412,479,AS cohort entry to exposure,9,1.878914405
MPCD,DMARD,Inflammatory bowel disease,Crohn’s Disease,412,479,12 months,19,3.9665970772
MPCD,DMARD,Inflammatory bowel disease,Crohn’s Disease,412,479,24 months,21,4.3841336117
MPCD,DMARD,Inflammatory bowel disease,Crohn’s Disease,412,479,36 months,21,4.3841336117
MPCD,DMARD,Inflammatory bowel disease,Crohn’s Disease,412,479,AS cohort entry to exposure,15,3.1315240084
MPCD,DMARD,Inflammatory bowel disease,Ulcerative Colitis,412,479,12 months,11,2.2964509395
MPCD,DMARD,Inflammatory bowel disease,Ulcerative Colitis,412,479,24 months,12,2.5052192067
MPCD,DMARD,Inflammatory bowel disease,Ulcerative Colitis,412,479,36 months,13,2.7139874739
MPCD,DMARD,Inflammatory bowel disease,Ulcerative Colitis,412,479,AS cohort entry to exposure,5,1.0438413361
MPCD,DMARD,Kidney disease,Amyloidosis,412,479,12 months,1,0.2087682672
MPCD,DMARD,Kidney disease,Amyloidosis,412,479,24 months,1,0.2087682672
MPCD,DMARD,Kidney disease,Amyloidosis,412,479,36 months,1,0.2087682672
MPCD,DMARD,Kidney disease,Amyloidosis,412,479,AS cohort entry to exposure,0,0
MPCD,DMARD,Kidney disease,IgA nephropathy,412,479,12 months,1,0.2087682672
MPCD,DMARD,Kidney disease,IgA nephropathy,412,479,24 months,1,0.2087682672
MPCD,DMARD,Kidney disease,IgA nephropathy,412,479,36 months,1,0.2087682672
MPCD,DMARD,Kidney disease,IgA nephropathy,412,479,AS cohort entry to exposure,1,0.2087682672
MPCD,DMARD,Lung disease,Apical Pulmonary fibrosis,412,479,12 months,1,0.2087682672
MPCD,DMARD,Lung disease,Apical Pulmonary fibrosis,412,479,24 months,1,0.2087682672
MPCD,DMARD,Lung disease,Apical Pulmonary fibrosis,412,479,36 months,1,0.2087682672
MPCD,DMARD,Lung disease,Apical Pulmonary fibrosis,412,479,AS cohort entry to exposure,0,0
MPCD,DMARD,Lung disease,Restrictive lung disease ,412,479,12 months,6,1.2526096033
MPCD,DMARD,Lung disease,Restrictive lung disease ,412,479,24 months,7,1.4613778706
MPCD,DMARD,Lung disease,Restrictive lung disease ,412,479,36 months,8,1.6701461378
MPCD,DMARD,Lung disease,Restrictive lung disease ,412,479,AS cohort entry to exposure,5,1.0438413361
MPCD,DMARD,Neurological Disease,Spinal Cord compression,412,479,12 months,1,0.2087682672
MPCD,DMARD,Neurological Disease,Spinal Cord compression,412,479,24 months,1,0.2087682672
MPCD,DMARD,Neurological Disease,Spinal Cord compression,412,479,36 months,1,0.2087682672
MPCD,DMARD,Neurological Disease,Spinal Cord compression,412,479,AS cohort entry to exposure,1,0.2087682672
MPCD,DMARD,Osteoporotic fracture,Clinical vertebral fracture,412,479,12 months,9,1.878914405
MPCD,DMARD,Osteoporotic fracture,Clinical vertebral fracture,412,479,24 months,10,2.0876826722
MPCD,DMARD,Osteoporotic fracture,Clinical vertebral fracture,412,479,36 months,10,2.0876826722
MPCD,DMARD,Osteoporotic fracture,Clinical vertebral fracture,412,479,AS cohort entry to exposure,3,0.6263048017
MPCD,DMARD,Osteoporotic fracture,Non-vertebral osteoporotic fracture,412,479,12 months,12,2.5052192067
MPCD,DMARD,Osteoporotic fracture,Non-vertebral osteoporotic fracture,412,479,24 months,15,3.1315240084
MPCD,DMARD,Osteoporotic fracture,Non-vertebral osteoporotic fracture,412,479,36 months,19,3.9665970772
MPCD,DMARD,Osteoporotic fracture,Non-vertebral osteoporotic fracture,412,479,AS cohort entry to exposure,5,1.0438413361
MPCD,DMARD,PsO/PsA,Psoriasis,412,479,12 months,17,3.5490605428
MPCD,DMARD,PsO/PsA,Psoriasis,412,479,24 months,18,3.75782881
MPCD,DMARD,PsO/PsA,Psoriasis,412,479,36 months,20,4.1753653445
MPCD,DMARD,PsO/PsA,Psoriasis,412,479,AS cohort entry to exposure,16,3.3402922756
MPCD,DMARD,PsO/PsA,Psoriatic arthritis,412,479,12 months,37,7.7244258873
MPCD,DMARD,PsO/PsA,Psoriatic arthritis,412,479,24 months,41,8.5594989562
MPCD,DMARD,PsO/PsA,Psoriatic arthritis,412,479,36 months,42,8.7682672234
MPCD,DMARD,PsO/PsA,Psoriatic arthritis,412,479,AS cohort entry to exposure,25,5.2192066806
MPCD,DMARD,Uveitis,Uveitis,412,479,12 months,24,5.0104384134
MPCD,DMARD,Uveitis,Uveitis,412,479,24 months,28,5.8455114823
MPCD,DMARD,Uveitis,Uveitis,412,479,36 months,29,6.0542797495
MPCD,DMARD,Uveitis,Uveitis,412,479,AS cohort entry to exposure,22,4.5929018789
MPCD,NSAID,Cancer,Hematologic Cancer,599,764,12 months,3,0.3926701571
MPCD,NSAID,Cancer,Hematologic Cancer,599,764,24 months,3,0.3926701571
MPCD,NSAID,Cancer,Hematologic Cancer,599,764,36 months,3,0.3926701571
MPCD,NSAID,Cancer,Hematologic Cancer,599,764,AS cohort entry to exposure,3,0.3926701571
MPCD,NSAID,Cancer,Solid Cancer,599,764,12 months,19,2.4869109948
MPCD,NSAID,Cancer,Solid Cancer,599,764,24 months,26,3.4031413613
MPCD,NSAID,Cancer,Solid Cancer,599,764,36 months,27,3.5340314136
MPCD,NSAID,Cancer,Solid Cancer,599,764,AS cohort entry to exposure,16,2.0942408377
MPCD,NSAID,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,599,764,12 months,4,0.5235602094
MPCD,NSAID,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,599,764,24 months,5,0.6544502618
MPCD,NSAID,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,599,764,36 months,5,0.6544502618
MPCD,NSAID,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,599,764,AS cohort entry to exposure,4,0.5235602094
MPCD,NSAID,Cardiac disease,Conduction Block,599,764,12 months,4,0.5235602094
MPCD,NSAID,Cardiac disease,Conduction Block,599,764,24 months,5,0.6544502618
MPCD,NSAID,Cardiac disease,Conduction Block,599,764,36 months,5,0.6544502618
MPCD,NSAID,Cardiac disease,Conduction Block,599,764,AS cohort entry to exposure,2,0.2617801047
MPCD,NSAID,Cardiac disease,Myocardial infarction,599,764,12 months,0,0
MPCD,NSAID,Cardiac disease,Myocardial infarction,599,764,24 months,0,0
MPCD,NSAID,Cardiac disease,Myocardial infarction,599,764,36 months,0,0
MPCD,NSAID,Cardiac disease,Myocardial infarction,599,764,AS cohort entry to exposure,1,0.1308900524
MPCD,NSAID,Infection,Hospitalized infection,599,764,12 months,3,0.3926701571
MPCD,NSAID,Infection,Hospitalized infection,599,764,24 months,8,1.0471204188
MPCD,NSAID,Infection,Hospitalized infection,599,764,36 months,10,1.3089005236
MPCD,NSAID,Infection,Hospitalized infection,599,764,AS cohort entry to exposure,0,0
MPCD,NSAID,Infection,Opportunistic infection,599,764,12 months,2,0.2617801047
MPCD,NSAID,Infection,Opportunistic infection,599,764,24 months,3,0.3926701571
MPCD,NSAID,Infection,Opportunistic infection,599,764,36 months,5,0.6544502618
MPCD,NSAID,Infection,Opportunistic infection,599,764,AS cohort entry to exposure,5,0.6544502618
MPCD,NSAID,Inflammatory bowel disease,Crohn’s Disease,599,764,12 months,19,2.4869109948
MPCD,NSAID,Inflammatory bowel disease,Crohn’s Disease,599,764,24 months,24,3.1413612565
MPCD,NSAID,Inflammatory bowel disease,Crohn’s Disease,599,764,36 months,25,3.2722513089
MPCD,NSAID,Inflammatory bowel disease,Crohn’s Disease,599,764,AS cohort entry to exposure,16,2.0942408377
MPCD,NSAID,Inflammatory bowel disease,Ulcerative Colitis,599,764,12 months,11,1.4397905759
MPCD,NSAID,Inflammatory bowel disease,Ulcerative Colitis,599,764,24 months,15,1.9633507853
MPCD,NSAID,Inflammatory bowel disease,Ulcerative Colitis,599,764,36 months,15,1.9633507853
MPCD,NSAID,Inflammatory bowel disease,Ulcerative Colitis,599,764,AS cohort entry to exposure,14,1.832460733
MPCD,NSAID,Kidney disease,IgA nephropathy,599,764,12 months,3,0.3926701571
MPCD,NSAID,Kidney disease,IgA nephropathy,599,764,24 months,4,0.5235602094
MPCD,NSAID,Kidney disease,IgA nephropathy,599,764,36 months,4,0.5235602094
MPCD,NSAID,Kidney disease,IgA nephropathy,599,764,AS cohort entry to exposure,1,0.1308900524
MPCD,NSAID,Lung disease,Restrictive lung disease ,599,764,12 months,9,1.1780104712
MPCD,NSAID,Lung disease,Restrictive lung disease ,599,764,24 months,14,1.832460733
MPCD,NSAID,Lung disease,Restrictive lung disease ,599,764,36 months,15,1.9633507853
MPCD,NSAID,Lung disease,Restrictive lung disease ,599,764,AS cohort entry to exposure,6,0.7853403141
MPCD,NSAID,Neurological Disease,Spinal Cord compression,599,764,12 months,2,0.2617801047
MPCD,NSAID,Neurological Disease,Spinal Cord compression,599,764,24 months,3,0.3926701571
MPCD,NSAID,Neurological Disease,Spinal Cord compression,599,764,36 months,3,0.3926701571
MPCD,NSAID,Neurological Disease,Spinal Cord compression,599,764,AS cohort entry to exposure,1,0.1308900524
MPCD,NSAID,Osteoporotic fracture,Clinical vertebral fracture,599,764,12 months,4,0.5235602094
MPCD,NSAID,Osteoporotic fracture,Clinical vertebral fracture,599,764,24 months,6,0.7853403141
MPCD,NSAID,Osteoporotic fracture,Clinical vertebral fracture,599,764,36 months,6,0.7853403141
MPCD,NSAID,Osteoporotic fracture,Clinical vertebral fracture,599,764,AS cohort entry to exposure,1,0.1308900524
MPCD,NSAID,Osteoporotic fracture,Non-vertebral osteoporotic fracture,599,764,12 months,19,2.4869109948
MPCD,NSAID,Osteoporotic fracture,Non-vertebral osteoporotic fracture,599,764,24 months,24,3.1413612565
MPCD,NSAID,Osteoporotic fracture,Non-vertebral osteoporotic fracture,599,764,36 months,27,3.5340314136
MPCD,NSAID,Osteoporotic fracture,Non-vertebral osteoporotic fracture,599,764,AS cohort entry to exposure,13,1.7015706806
MPCD,NSAID,PsO/PsA,Psoriasis,599,764,12 months,8,1.0471204188
MPCD,NSAID,PsO/PsA,Psoriasis,599,764,24 months,11,1.4397905759
MPCD,NSAID,PsO/PsA,Psoriasis,599,764,36 months,19,2.4869109948
MPCD,NSAID,PsO/PsA,Psoriasis,599,764,AS cohort entry to exposure,12,1.5706806283
MPCD,NSAID,PsO/PsA,Psoriatic arthritis,599,764,12 months,25,3.2722513089
MPCD,NSAID,PsO/PsA,Psoriatic arthritis,599,764,24 months,31,4.057591623
MPCD,NSAID,PsO/PsA,Psoriatic arthritis,599,764,36 months,34,4.4502617801
MPCD,NSAID,PsO/PsA,Psoriatic arthritis,599,764,AS cohort entry to exposure,24,3.1413612565
MPCD,NSAID,Uveitis,Uveitis,599,764,12 months,32,4.1884816754
MPCD,NSAID,Uveitis,Uveitis,599,764,24 months,36,4.7120418848
MPCD,NSAID,Uveitis,Uveitis,599,764,36 months,36,4.7120418848
MPCD,NSAID,Uveitis,Uveitis,599,764,AS cohort entry to exposure,34,4.4502617801
MPCD,No exposure,Cancer,Hematologic Cancer,1518,1518,12 months,36,2.371541502
MPCD,No exposure,Cancer,Hematologic Cancer,1518,1518,24 months,38,2.5032938076
MPCD,No exposure,Cancer,Hematologic Cancer,1518,1518,36 months,41,2.7009222661
MPCD,No exposure,Cancer,Hematologic Cancer,1518,1518,AS cohort entry to exposure,23,1.5151515152
MPCD,No exposure,Cancer,Solid Cancer,1518,1518,12 months,100,6.5876152833
MPCD,No exposure,Cancer,Solid Cancer,1518,1518,24 months,123,8.1027667984
MPCD,No exposure,Cancer,Solid Cancer,1518,1518,36 months,136,8.9591567852
MPCD,No exposure,Cancer,Solid Cancer,1518,1518,AS cohort entry to exposure,29,1.9104084321
MPCD,No exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1518,1518,12 months,60,3.95256917
MPCD,No exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1518,1518,24 months,67,4.4137022398
MPCD,No exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1518,1518,36 months,72,4.743083004
MPCD,No exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1518,1518,AS cohort entry to exposure,25,1.6469038208
MPCD,No exposure,Cardiac disease,Conduction Block,1518,1518,12 months,39,2.5691699605
MPCD,No exposure,Cardiac disease,Conduction Block,1518,1518,24 months,45,2.9644268775
MPCD,No exposure,Cardiac disease,Conduction Block,1518,1518,36 months,48,3.162055336
MPCD,No exposure,Cardiac disease,Conduction Block,1518,1518,AS cohort entry to exposure,23,1.5151515152
MPCD,No exposure,Cardiac disease,Myocardial infarction,1518,1518,12 months,2,0.1317523057
MPCD,No exposure,Cardiac disease,Myocardial infarction,1518,1518,24 months,5,0.3293807642
MPCD,No exposure,Cardiac disease,Myocardial infarction,1518,1518,36 months,6,0.395256917
MPCD,No exposure,Cardiac disease,Myocardial infarction,1518,1518,AS cohort entry to exposure,0,0
MPCD,No exposure,Infection,Hospitalized infection,1518,1518,12 months,36,2.371541502
MPCD,No exposure,Infection,Hospitalized infection,1518,1518,24 months,62,4.0843214756
MPCD,No exposure,Infection,Hospitalized infection,1518,1518,36 months,73,4.8089591568
MPCD,No exposure,Infection,Hospitalized infection,1518,1518,AS cohort entry to exposure,0,0
MPCD,No exposure,Infection,Opportunistic infection,1518,1518,12 months,37,2.4374176548
MPCD,No exposure,Infection,Opportunistic infection,1518,1518,24 months,44,2.8985507246
MPCD,No exposure,Infection,Opportunistic infection,1518,1518,36 months,48,3.162055336
MPCD,No exposure,Infection,Opportunistic infection,1518,1518,AS cohort entry to exposure,27,1.7786561265
MPCD,No exposure,Inflammatory bowel disease,Crohn’s Disease,1518,1518,12 months,88,5.7971014493
MPCD,No exposure,Inflammatory bowel disease,Crohn’s Disease,1518,1518,24 months,95,6.2582345191
MPCD,No exposure,Inflammatory bowel disease,Crohn’s Disease,1518,1518,36 months,103,6.7852437418
MPCD,No exposure,Inflammatory bowel disease,Crohn’s Disease,1518,1518,AS cohort entry to exposure,42,2.766798419
MPCD,No exposure,Inflammatory bowel disease,Ulcerative Colitis,1518,1518,12 months,63,4.1501976285
MPCD,No exposure,Inflammatory bowel disease,Ulcerative Colitis,1518,1518,24 months,67,4.4137022398
MPCD,No exposure,Inflammatory bowel disease,Ulcerative Colitis,1518,1518,36 months,73,4.8089591568
MPCD,No exposure,Inflammatory bowel disease,Ulcerative Colitis,1518,1518,AS cohort entry to exposure,11,0.7246376812
MPCD,No exposure,Kidney disease,Amyloidosis,1518,1518,12 months,20,1.3175230567
MPCD,No exposure,Kidney disease,Amyloidosis,1518,1518,24 months,21,1.3833992095
MPCD,No exposure,Kidney disease,Amyloidosis,1518,1518,36 months,23,1.5151515152
MPCD,No exposure,Kidney disease,Amyloidosis,1518,1518,AS cohort entry to exposure,4,0.2635046113
MPCD,No exposure,Kidney disease,IgA nephropathy,1518,1518,12 months,1,0.0658761528
MPCD,No exposure,Kidney disease,IgA nephropathy,1518,1518,24 months,2,0.1317523057
MPCD,No exposure,Kidney disease,IgA nephropathy,1518,1518,36 months,4,0.2635046113
MPCD,No exposure,Kidney disease,IgA nephropathy,1518,1518,AS cohort entry to exposure,0,0
MPCD,No exposure,Kidney disease,Nephrotic syndrome,1518,1518,12 months,0,0
MPCD,No exposure,Kidney disease,Nephrotic syndrome,1518,1518,24 months,1,0.0658761528
MPCD,No exposure,Kidney disease,Nephrotic syndrome,1518,1518,36 months,1,0.0658761528
MPCD,No exposure,Kidney disease,Nephrotic syndrome,1518,1518,AS cohort entry to exposure,0,0
MPCD,No exposure,Lung disease,Apical Pulmonary fibrosis,1518,1518,12 months,5,0.3293807642
MPCD,No exposure,Lung disease,Apical Pulmonary fibrosis,1518,1518,24 months,6,0.395256917
MPCD,No exposure,Lung disease,Apical Pulmonary fibrosis,1518,1518,36 months,7,0.4611330698
MPCD,No exposure,Lung disease,Apical Pulmonary fibrosis,1518,1518,AS cohort entry to exposure,2,0.1317523057
MPCD,No exposure,Lung disease,Interstitial lung disease,1518,1518,12 months,0,0
MPCD,No exposure,Lung disease,Interstitial lung disease,1518,1518,24 months,1,0.0658761528
MPCD,No exposure,Lung disease,Interstitial lung disease,1518,1518,36 months,1,0.0658761528
MPCD,No exposure,Lung disease,Interstitial lung disease,1518,1518,AS cohort entry to exposure,0,0
MPCD,No exposure,Lung disease,Restrictive lung disease ,1518,1518,12 months,48,3.162055336
MPCD,No exposure,Lung disease,Restrictive lung disease ,1518,1518,24 months,55,3.6231884058
MPCD,No exposure,Lung disease,Restrictive lung disease ,1518,1518,36 months,61,4.0184453228
MPCD,No exposure,Lung disease,Restrictive lung disease ,1518,1518,AS cohort entry to exposure,13,0.8563899868
MPCD,No exposure,Neurological Disease,Cauda Equina syndrome,1518,1518,12 months,1,0.0658761528
MPCD,No exposure,Neurological Disease,Cauda Equina syndrome,1518,1518,24 months,2,0.1317523057
MPCD,No exposure,Neurological Disease,Cauda Equina syndrome,1518,1518,36 months,2,0.1317523057
MPCD,No exposure,Neurological Disease,Cauda Equina syndrome,1518,1518,AS cohort entry to exposure,0,0
MPCD,No exposure,Neurological Disease,Spinal Cord compression,1518,1518,12 months,3,0.1976284585
MPCD,No exposure,Neurological Disease,Spinal Cord compression,1518,1518,24 months,3,0.1976284585
MPCD,No exposure,Neurological Disease,Spinal Cord compression,1518,1518,36 months,4,0.2635046113
MPCD,No exposure,Neurological Disease,Spinal Cord compression,1518,1518,AS cohort entry to exposure,1,0.0658761528
MPCD,No exposure,Osteoporotic fracture,Clinical vertebral fracture,1518,1518,12 months,55,3.6231884058
MPCD,No exposure,Osteoporotic fracture,Clinical vertebral fracture,1518,1518,24 months,69,4.5454545455
MPCD,No exposure,Osteoporotic fracture,Clinical vertebral fracture,1518,1518,36 months,71,4.6772068511
MPCD,No exposure,Osteoporotic fracture,Clinical vertebral fracture,1518,1518,AS cohort entry to exposure,3,0.1976284585
MPCD,No exposure,Osteoporotic fracture,Non-vertebral osteoporotic fracture,1518,1518,12 months,54,3.557312253
MPCD,No exposure,Osteoporotic fracture,Non-vertebral osteoporotic fracture,1518,1518,24 months,79,5.2042160738
MPCD,No exposure,Osteoporotic fracture,Non-vertebral osteoporotic fracture,1518,1518,36 months,91,5.9947299078
MPCD,No exposure,Osteoporotic fracture,Non-vertebral osteoporotic fracture,1518,1518,AS cohort entry to exposure,9,0.5928853755
MPCD,No exposure,PsO/PsA,Psoriasis,1518,1518,12 months,39,2.5691699605
MPCD,No exposure,PsO/PsA,Psoriasis,1518,1518,24 months,51,3.3596837945
MPCD,No exposure,PsO/PsA,Psoriasis,1518,1518,36 months,53,3.4914361001
MPCD,No exposure,PsO/PsA,Psoriasis,1518,1518,AS cohort entry to exposure,11,0.7246376812
MPCD,No exposure,PsO/PsA,Psoriatic arthritis,1518,1518,12 months,85,5.5994729908
MPCD,No exposure,PsO/PsA,Psoriatic arthritis,1518,1518,24 months,101,6.6534914361
MPCD,No exposure,PsO/PsA,Psoriatic arthritis,1518,1518,36 months,108,7.1146245059
MPCD,No exposure,PsO/PsA,Psoriatic arthritis,1518,1518,AS cohort entry to exposure,50,3.2938076416
MPCD,No exposure,Uveitis,Uveitis,1518,1518,12 months,87,5.7312252964
MPCD,No exposure,Uveitis,Uveitis,1518,1518,24 months,109,7.1805006588
MPCD,No exposure,Uveitis,Uveitis,1518,1518,36 months,114,7.5098814229
MPCD,No exposure,Uveitis,Uveitis,1518,1518,AS cohort entry to exposure,25,1.6469038208
MPCD,TNF,Cancer,Hematologic Cancer,755,859,12 months,1,0.1164144354
MPCD,TNF,Cancer,Hematologic Cancer,755,859,24 months,2,0.2328288708
MPCD,TNF,Cancer,Hematologic Cancer,755,859,36 months,2,0.2328288708
MPCD,TNF,Cancer,Hematologic Cancer,755,859,AS cohort entry to exposure,1,0.1164144354
MPCD,TNF,Cancer,Solid Cancer,755,859,12 months,19,2.2118742724
MPCD,TNF,Cancer,Solid Cancer,755,859,24 months,22,2.5611175786
MPCD,TNF,Cancer,Solid Cancer,755,859,36 months,25,2.9103608847
MPCD,TNF,Cancer,Solid Cancer,755,859,AS cohort entry to exposure,13,1.5133876601
MPCD,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,755,859,12 months,12,1.3969732247
MPCD,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,755,859,24 months,13,1.5133876601
MPCD,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,755,859,36 months,13,1.5133876601
MPCD,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,755,859,AS cohort entry to exposure,10,1.1641443539
MPCD,TNF,Cardiac disease,Conduction Block,755,859,12 months,2,0.2328288708
MPCD,TNF,Cardiac disease,Conduction Block,755,859,24 months,2,0.2328288708
MPCD,TNF,Cardiac disease,Conduction Block,755,859,36 months,2,0.2328288708
MPCD,TNF,Cardiac disease,Conduction Block,755,859,AS cohort entry to exposure,1,0.1164144354
MPCD,TNF,Cardiac disease,Myocardial infarction,755,859,12 months,1,0.1164144354
MPCD,TNF,Cardiac disease,Myocardial infarction,755,859,24 months,1,0.1164144354
MPCD,TNF,Cardiac disease,Myocardial infarction,755,859,36 months,1,0.1164144354
MPCD,TNF,Cardiac disease,Myocardial infarction,755,859,AS cohort entry to exposure,1,0.1164144354
MPCD,TNF,Infection,Hospitalized infection,755,859,12 months,3,0.3492433062
MPCD,TNF,Infection,Hospitalized infection,755,859,24 months,5,0.5820721769
MPCD,TNF,Infection,Hospitalized infection,755,859,36 months,6,0.6984866123
MPCD,TNF,Infection,Hospitalized infection,755,859,AS cohort entry to exposure,2,0.2328288708
MPCD,TNF,Infection,Opportunistic infection,755,859,12 months,9,1.0477299185
MPCD,TNF,Infection,Opportunistic infection,755,859,24 months,15,1.7462165308
MPCD,TNF,Infection,Opportunistic infection,755,859,36 months,16,1.8626309662
MPCD,TNF,Infection,Opportunistic infection,755,859,AS cohort entry to exposure,7,0.8149010477
MPCD,TNF,Inflammatory bowel disease,Crohn’s Disease,755,859,12 months,58,6.7520372526
MPCD,TNF,Inflammatory bowel disease,Crohn’s Disease,755,859,24 months,61,7.1012805588
MPCD,TNF,Inflammatory bowel disease,Crohn’s Disease,755,859,36 months,65,7.5669383003
MPCD,TNF,Inflammatory bowel disease,Crohn’s Disease,755,859,AS cohort entry to exposure,55,6.4027939464
MPCD,TNF,Inflammatory bowel disease,Ulcerative Colitis,755,859,12 months,19,2.2118742724
MPCD,TNF,Inflammatory bowel disease,Ulcerative Colitis,755,859,24 months,22,2.5611175786
MPCD,TNF,Inflammatory bowel disease,Ulcerative Colitis,755,859,36 months,23,2.677532014
MPCD,TNF,Inflammatory bowel disease,Ulcerative Colitis,755,859,AS cohort entry to exposure,20,2.3282887078
MPCD,TNF,Kidney disease,IgA nephropathy,755,859,12 months,4,0.4656577416
MPCD,TNF,Kidney disease,IgA nephropathy,755,859,24 months,4,0.4656577416
MPCD,TNF,Kidney disease,IgA nephropathy,755,859,36 months,4,0.4656577416
MPCD,TNF,Kidney disease,IgA nephropathy,755,859,AS cohort entry to exposure,3,0.3492433062
MPCD,TNF,Kidney disease,Nephrotic syndrome,755,859,12 months,2,0.2328288708
MPCD,TNF,Kidney disease,Nephrotic syndrome,755,859,24 months,2,0.2328288708
MPCD,TNF,Kidney disease,Nephrotic syndrome,755,859,36 months,2,0.2328288708
MPCD,TNF,Kidney disease,Nephrotic syndrome,755,859,AS cohort entry to exposure,0,0
MPCD,TNF,Lung disease,Restrictive lung disease ,755,859,12 months,5,0.5820721769
MPCD,TNF,Lung disease,Restrictive lung disease ,755,859,24 months,7,0.8149010477
MPCD,TNF,Lung disease,Restrictive lung disease ,755,859,36 months,8,0.9313154831
MPCD,TNF,Lung disease,Restrictive lung disease ,755,859,AS cohort entry to exposure,6,0.6984866123
MPCD,TNF,Neurological Disease,Spinal Cord compression,755,859,12 months,2,0.2328288708
MPCD,TNF,Neurological Disease,Spinal Cord compression,755,859,24 months,2,0.2328288708
MPCD,TNF,Neurological Disease,Spinal Cord compression,755,859,36 months,2,0.2328288708
MPCD,TNF,Neurological Disease,Spinal Cord compression,755,859,AS cohort entry to exposure,0,0
MPCD,TNF,Osteoporotic fracture,Clinical vertebral fracture,755,859,12 months,9,1.0477299185
MPCD,TNF,Osteoporotic fracture,Clinical vertebral fracture,755,859,24 months,10,1.1641443539
MPCD,TNF,Osteoporotic fracture,Clinical vertebral fracture,755,859,36 months,10,1.1641443539
MPCD,TNF,Osteoporotic fracture,Clinical vertebral fracture,755,859,AS cohort entry to exposure,6,0.6984866123
MPCD,TNF,Osteoporotic fracture,Non-vertebral osteoporotic fracture,755,859,12 months,15,1.7462165308
MPCD,TNF,Osteoporotic fracture,Non-vertebral osteoporotic fracture,755,859,24 months,22,2.5611175786
MPCD,TNF,Osteoporotic fracture,Non-vertebral osteoporotic fracture,755,859,36 months,23,2.677532014
MPCD,TNF,Osteoporotic fracture,Non-vertebral osteoporotic fracture,755,859,AS cohort entry to exposure,9,1.0477299185
MPCD,TNF,PsO/PsA,Psoriasis,755,859,12 months,42,4.8894062864
MPCD,TNF,PsO/PsA,Psoriasis,755,859,24 months,52,6.0535506403
MPCD,TNF,PsO/PsA,Psoriasis,755,859,36 months,53,6.1699650757
MPCD,TNF,PsO/PsA,Psoriasis,755,859,AS cohort entry to exposure,30,3.4924330617
MPCD,TNF,PsO/PsA,Psoriatic arthritis,755,859,12 months,69,8.0325960419
MPCD,TNF,PsO/PsA,Psoriatic arthritis,755,859,24 months,82,9.545983702
MPCD,TNF,PsO/PsA,Psoriatic arthritis,755,859,36 months,85,9.8952270081
MPCD,TNF,PsO/PsA,Psoriatic arthritis,755,859,AS cohort entry to exposure,61,7.1012805588
MPCD,TNF,Uveitis,Uveitis,755,859,12 months,60,6.9848661234
MPCD,TNF,Uveitis,Uveitis,755,859,24 months,72,8.3818393481
MPCD,TNF,Uveitis,Uveitis,755,859,36 months,74,8.6146682189
MPCD,TNF,Uveitis,Uveitis,755,859,AS cohort entry to exposure,48,5.5878928987
Marketscan,DMARD,Cancer,Hematologic Cancer,1703,1928,12 months,14,0.7261410788
Marketscan,DMARD,Cancer,Hematologic Cancer,1703,1928,24 months,18,0.9336099585
Marketscan,DMARD,Cancer,Hematologic Cancer,1703,1928,36 months,19,0.9854771784
Marketscan,DMARD,Cancer,Hematologic Cancer,1703,1928,AS cohort entry to exposure,10,0.5186721992
Marketscan,DMARD,Cancer,Non Melanoma Skin Cancer,1703,1928,12 months,12,0.622406639
Marketscan,DMARD,Cancer,Non Melanoma Skin Cancer,1703,1928,24 months,24,1.244813278
Marketscan,DMARD,Cancer,Non Melanoma Skin Cancer,1703,1928,36 months,28,1.4522821577
Marketscan,DMARD,Cancer,Non Melanoma Skin Cancer,1703,1928,AS cohort entry to exposure,12,0.622406639
Marketscan,DMARD,Cancer,Solid Cancer,1703,1928,12 months,76,3.9419087137
Marketscan,DMARD,Cancer,Solid Cancer,1703,1928,24 months,85,4.4087136929
Marketscan,DMARD,Cancer,Solid Cancer,1703,1928,36 months,91,4.7199170124
Marketscan,DMARD,Cancer,Solid Cancer,1703,1928,AS cohort entry to exposure,51,2.6452282158
Marketscan,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1703,1928,12 months,16,0.8298755187
Marketscan,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1703,1928,24 months,24,1.244813278
Marketscan,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1703,1928,36 months,29,1.5041493776
Marketscan,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1703,1928,AS cohort entry to exposure,16,0.8298755187
Marketscan,DMARD,Cardiac disease,Conduction Block,1703,1928,12 months,18,0.9336099585
Marketscan,DMARD,Cardiac disease,Conduction Block,1703,1928,24 months,26,1.3485477178
Marketscan,DMARD,Cardiac disease,Conduction Block,1703,1928,36 months,29,1.5041493776
Marketscan,DMARD,Cardiac disease,Conduction Block,1703,1928,AS cohort entry to exposure,11,0.5705394191
Marketscan,DMARD,Cardiac disease,Myocardial infarction,1703,1928,12 months,3,0.1556016598
Marketscan,DMARD,Cardiac disease,Myocardial infarction,1703,1928,24 months,5,0.2593360996
Marketscan,DMARD,Cardiac disease,Myocardial infarction,1703,1928,36 months,7,0.3630705394
Marketscan,DMARD,Cardiac disease,Myocardial infarction,1703,1928,AS cohort entry to exposure,2,0.1037344398
Marketscan,DMARD,Infection,Hospitalized infection,1703,1928,12 months,59,3.0601659751
Marketscan,DMARD,Infection,Hospitalized infection,1703,1928,24 months,91,4.7199170124
Marketscan,DMARD,Infection,Hospitalized infection,1703,1928,36 months,101,5.2385892116
Marketscan,DMARD,Infection,Hospitalized infection,1703,1928,AS cohort entry to exposure,47,2.4377593361
Marketscan,DMARD,Infection,Opportunistic infection,1703,1928,12 months,30,1.5560165975
Marketscan,DMARD,Infection,Opportunistic infection,1703,1928,24 months,40,2.0746887967
Marketscan,DMARD,Infection,Opportunistic infection,1703,1928,36 months,48,2.489626556
Marketscan,DMARD,Infection,Opportunistic infection,1703,1928,AS cohort entry to exposure,19,0.9854771784
Marketscan,DMARD,Inflammatory bowel disease,Crohn’s Disease,1703,1928,12 months,68,3.5269709544
Marketscan,DMARD,Inflammatory bowel disease,Crohn’s Disease,1703,1928,24 months,78,4.0456431535
Marketscan,DMARD,Inflammatory bowel disease,Crohn’s Disease,1703,1928,36 months,83,4.3049792531
Marketscan,DMARD,Inflammatory bowel disease,Crohn’s Disease,1703,1928,AS cohort entry to exposure,55,2.8526970954
Marketscan,DMARD,Inflammatory bowel disease,Ulcerative Colitis,1703,1928,12 months,51,2.6452282158
Marketscan,DMARD,Inflammatory bowel disease,Ulcerative Colitis,1703,1928,24 months,62,3.2157676349
Marketscan,DMARD,Inflammatory bowel disease,Ulcerative Colitis,1703,1928,36 months,66,3.4232365145
Marketscan,DMARD,Inflammatory bowel disease,Ulcerative Colitis,1703,1928,AS cohort entry to exposure,34,1.7634854772
Marketscan,DMARD,Kidney disease,Amyloidosis,1703,1928,12 months,0,0
Marketscan,DMARD,Kidney disease,Amyloidosis,1703,1928,24 months,2,0.1037344398
Marketscan,DMARD,Kidney disease,Amyloidosis,1703,1928,36 months,2,0.1037344398
Marketscan,DMARD,Kidney disease,Amyloidosis,1703,1928,AS cohort entry to exposure,0,0
Marketscan,DMARD,Kidney disease,IgA nephropathy,1703,1928,12 months,1,0.0518672199
Marketscan,DMARD,Kidney disease,IgA nephropathy,1703,1928,24 months,1,0.0518672199
Marketscan,DMARD,Kidney disease,IgA nephropathy,1703,1928,36 months,3,0.1556016598
Marketscan,DMARD,Kidney disease,IgA nephropathy,1703,1928,AS cohort entry to exposure,1,0.0518672199
Marketscan,DMARD,Kidney disease,Nephrotic syndrome,1703,1928,12 months,0,0
Marketscan,DMARD,Kidney disease,Nephrotic syndrome,1703,1928,24 months,0,0
Marketscan,DMARD,Kidney disease,Nephrotic syndrome,1703,1928,36 months,2,0.1037344398
Marketscan,DMARD,Kidney disease,Nephrotic syndrome,1703,1928,AS cohort entry to exposure,0,0
Marketscan,DMARD,Lung disease,Interstitial lung disease,1703,1928,12 months,2,0.1037344398
Marketscan,DMARD,Lung disease,Interstitial lung disease,1703,1928,24 months,2,0.1037344398
Marketscan,DMARD,Lung disease,Interstitial lung disease,1703,1928,36 months,3,0.1556016598
Marketscan,DMARD,Lung disease,Interstitial lung disease,1703,1928,AS cohort entry to exposure,1,0.0518672199
Marketscan,DMARD,Lung disease,Restrictive lung disease ,1703,1928,12 months,16,0.8298755187
Marketscan,DMARD,Lung disease,Restrictive lung disease ,1703,1928,24 months,23,1.1929460581
Marketscan,DMARD,Lung disease,Restrictive lung disease ,1703,1928,36 months,30,1.5560165975
Marketscan,DMARD,Lung disease,Restrictive lung disease ,1703,1928,AS cohort entry to exposure,17,0.8817427386
Marketscan,DMARD,Neurological Disease,Spinal Cord compression,1703,1928,12 months,2,0.1037344398
Marketscan,DMARD,Neurological Disease,Spinal Cord compression,1703,1928,24 months,2,0.1037344398
Marketscan,DMARD,Neurological Disease,Spinal Cord compression,1703,1928,36 months,3,0.1556016598
Marketscan,DMARD,Neurological Disease,Spinal Cord compression,1703,1928,AS cohort entry to exposure,2,0.1037344398
Marketscan,DMARD,Osteoporotic fracture,Clinical vertebral fracture,1703,1928,12 months,10,0.5186721992
Marketscan,DMARD,Osteoporotic fracture,Clinical vertebral fracture,1703,1928,24 months,15,0.7780082988
Marketscan,DMARD,Osteoporotic fracture,Clinical vertebral fracture,1703,1928,36 months,17,0.8817427386
Marketscan,DMARD,Osteoporotic fracture,Clinical vertebral fracture,1703,1928,AS cohort entry to exposure,4,0.2074688797
Marketscan,DMARD,Osteoporotic fracture,Non-vertebral osteoporotic fracture,1703,1928,12 months,18,0.9336099585
Marketscan,DMARD,Osteoporotic fracture,Non-vertebral osteoporotic fracture,1703,1928,24 months,31,1.6078838174
Marketscan,DMARD,Osteoporotic fracture,Non-vertebral osteoporotic fracture,1703,1928,36 months,39,2.0228215768
Marketscan,DMARD,Osteoporotic fracture,Non-vertebral osteoporotic fracture,1703,1928,AS cohort entry to exposure,18,0.9336099585
Marketscan,DMARD,PsO/PsA,Psoriasis,1703,1928,12 months,88,4.5643153527
Marketscan,DMARD,PsO/PsA,Psoriasis,1703,1928,24 months,109,5.653526971
Marketscan,DMARD,PsO/PsA,Psoriasis,1703,1928,36 months,115,5.9647302905
Marketscan,DMARD,PsO/PsA,Psoriasis,1703,1928,AS cohort entry to exposure,75,3.8900414938
Marketscan,DMARD,PsO/PsA,Psoriatic arthritis,1703,1928,12 months,162,8.4024896266
Marketscan,DMARD,PsO/PsA,Psoriatic arthritis,1703,1928,24 months,191,9.9066390041
Marketscan,DMARD,PsO/PsA,Psoriatic arthritis,1703,1928,36 months,196,10.165975104
Marketscan,DMARD,PsO/PsA,Psoriatic arthritis,1703,1928,AS cohort entry to exposure,111,5.7572614108
Marketscan,DMARD,Uveitis,Uveitis,1703,1928,12 months,105,5.4460580913
Marketscan,DMARD,Uveitis,Uveitis,1703,1928,24 months,126,6.5352697095
Marketscan,DMARD,Uveitis,Uveitis,1703,1928,36 months,134,6.9502074689
Marketscan,DMARD,Uveitis,Uveitis,1703,1928,AS cohort entry to exposure,80,4.1493775934
Marketscan,NSAID,Cancer,Hematologic Cancer,2771,3590,12 months,18,0.5013927577
Marketscan,NSAID,Cancer,Hematologic Cancer,2771,3590,24 months,23,0.6406685237
Marketscan,NSAID,Cancer,Hematologic Cancer,2771,3590,36 months,23,0.6406685237
Marketscan,NSAID,Cancer,Hematologic Cancer,2771,3590,AS cohort entry to exposure,17,0.4735376045
Marketscan,NSAID,Cancer,Non Melanoma Skin Cancer,2771,3590,12 months,25,0.6963788301
Marketscan,NSAID,Cancer,Non Melanoma Skin Cancer,2771,3590,24 months,44,1.2256267409
Marketscan,NSAID,Cancer,Non Melanoma Skin Cancer,2771,3590,36 months,48,1.3370473538
Marketscan,NSAID,Cancer,Non Melanoma Skin Cancer,2771,3590,AS cohort entry to exposure,33,0.9192200557
Marketscan,NSAID,Cancer,Solid Cancer,2771,3590,12 months,142,3.9554317549
Marketscan,NSAID,Cancer,Solid Cancer,2771,3590,24 months,177,4.930362117
Marketscan,NSAID,Cancer,Solid Cancer,2771,3590,36 months,183,5.0974930362
Marketscan,NSAID,Cancer,Solid Cancer,2771,3590,AS cohort entry to exposure,124,3.4540389972
Marketscan,NSAID,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,2771,3590,12 months,38,1.0584958217
Marketscan,NSAID,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,2771,3590,24 months,47,1.3091922006
Marketscan,NSAID,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,2771,3590,36 months,49,1.364902507
Marketscan,NSAID,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,2771,3590,AS cohort entry to exposure,39,1.0863509749
Marketscan,NSAID,Cardiac disease,Conduction Block,2771,3590,12 months,36,1.0027855153
Marketscan,NSAID,Cardiac disease,Conduction Block,2771,3590,24 months,49,1.364902507
Marketscan,NSAID,Cardiac disease,Conduction Block,2771,3590,36 months,55,1.5320334262
Marketscan,NSAID,Cardiac disease,Conduction Block,2771,3590,AS cohort entry to exposure,31,0.8635097493
Marketscan,NSAID,Cardiac disease,Myocardial infarction,2771,3590,12 months,6,0.1671309192
Marketscan,NSAID,Cardiac disease,Myocardial infarction,2771,3590,24 months,11,0.3064066852
Marketscan,NSAID,Cardiac disease,Myocardial infarction,2771,3590,36 months,12,0.3342618384
Marketscan,NSAID,Cardiac disease,Myocardial infarction,2771,3590,AS cohort entry to exposure,7,0.1949860724
Marketscan,NSAID,Infection,Hospitalized infection,2771,3590,12 months,114,3.1754874652
Marketscan,NSAID,Infection,Hospitalized infection,2771,3590,24 months,166,4.6239554318
Marketscan,NSAID,Infection,Hospitalized infection,2771,3590,36 months,195,5.4317548747
Marketscan,NSAID,Infection,Hospitalized infection,2771,3590,AS cohort entry to exposure,127,3.5376044568
Marketscan,NSAID,Infection,Opportunistic infection,2771,3590,12 months,22,0.6128133705
Marketscan,NSAID,Infection,Opportunistic infection,2771,3590,24 months,38,1.0584958217
Marketscan,NSAID,Infection,Opportunistic infection,2771,3590,36 months,43,1.1977715877
Marketscan,NSAID,Infection,Opportunistic infection,2771,3590,AS cohort entry to exposure,23,0.6406685237
Marketscan,NSAID,Inflammatory bowel disease,Crohn’s Disease,2771,3590,12 months,113,3.147632312
Marketscan,NSAID,Inflammatory bowel disease,Crohn’s Disease,2771,3590,24 months,133,3.704735376
Marketscan,NSAID,Inflammatory bowel disease,Crohn’s Disease,2771,3590,36 months,140,3.8997214485
Marketscan,NSAID,Inflammatory bowel disease,Crohn’s Disease,2771,3590,AS cohort entry to exposure,108,3.008356546
Marketscan,NSAID,Inflammatory bowel disease,Ulcerative Colitis,2771,3590,12 months,70,1.9498607242
Marketscan,NSAID,Inflammatory bowel disease,Ulcerative Colitis,2771,3590,24 months,81,2.2562674095
Marketscan,NSAID,Inflammatory bowel disease,Ulcerative Colitis,2771,3590,36 months,86,2.3955431755
Marketscan,NSAID,Inflammatory bowel disease,Ulcerative Colitis,2771,3590,AS cohort entry to exposure,60,1.6713091922
Marketscan,NSAID,Kidney disease,Amyloidosis,2771,3590,12 months,0,0
Marketscan,NSAID,Kidney disease,Amyloidosis,2771,3590,24 months,1,0.0278551532
Marketscan,NSAID,Kidney disease,Amyloidosis,2771,3590,36 months,1,0.0278551532
Marketscan,NSAID,Kidney disease,Amyloidosis,2771,3590,AS cohort entry to exposure,0,0
Marketscan,NSAID,Kidney disease,IgA nephropathy,2771,3590,12 months,2,0.0557103064
Marketscan,NSAID,Kidney disease,IgA nephropathy,2771,3590,24 months,3,0.0835654596
Marketscan,NSAID,Kidney disease,IgA nephropathy,2771,3590,36 months,3,0.0835654596
Marketscan,NSAID,Kidney disease,IgA nephropathy,2771,3590,AS cohort entry to exposure,0,0
Marketscan,NSAID,Kidney disease,Nephrotic syndrome,2771,3590,12 months,0,0
Marketscan,NSAID,Kidney disease,Nephrotic syndrome,2771,3590,24 months,1,0.0278551532
Marketscan,NSAID,Kidney disease,Nephrotic syndrome,2771,3590,36 months,2,0.0557103064
Marketscan,NSAID,Kidney disease,Nephrotic syndrome,2771,3590,AS cohort entry to exposure,0,0
Marketscan,NSAID,Lung disease,Interstitial lung disease,2771,3590,12 months,0,0
Marketscan,NSAID,Lung disease,Interstitial lung disease,2771,3590,24 months,1,0.0278551532
Marketscan,NSAID,Lung disease,Interstitial lung disease,2771,3590,36 months,1,0.0278551532
Marketscan,NSAID,Lung disease,Interstitial lung disease,2771,3590,AS cohort entry to exposure,3,0.0835654596
Marketscan,NSAID,Lung disease,Restrictive lung disease ,2771,3590,12 months,35,0.9749303621
Marketscan,NSAID,Lung disease,Restrictive lung disease ,2771,3590,24 months,41,1.1420612813
Marketscan,NSAID,Lung disease,Restrictive lung disease ,2771,3590,36 months,46,1.2813370474
Marketscan,NSAID,Lung disease,Restrictive lung disease ,2771,3590,AS cohort entry to exposure,44,1.2256267409
Marketscan,NSAID,Neurological Disease,Cauda Equina syndrome,2771,3590,12 months,2,0.0557103064
Marketscan,NSAID,Neurological Disease,Cauda Equina syndrome,2771,3590,24 months,2,0.0557103064
Marketscan,NSAID,Neurological Disease,Cauda Equina syndrome,2771,3590,36 months,2,0.0557103064
Marketscan,NSAID,Neurological Disease,Cauda Equina syndrome,2771,3590,AS cohort entry to exposure,0,0
Marketscan,NSAID,Neurological Disease,Spinal Cord compression,2771,3590,12 months,13,0.3621169916
Marketscan,NSAID,Neurological Disease,Spinal Cord compression,2771,3590,24 months,19,0.5292479109
Marketscan,NSAID,Neurological Disease,Spinal Cord compression,2771,3590,36 months,20,0.5571030641
Marketscan,NSAID,Neurological Disease,Spinal Cord compression,2771,3590,AS cohort entry to exposure,10,0.278551532
Marketscan,NSAID,Osteoporotic fracture,Clinical vertebral fracture,2771,3590,12 months,36,1.0027855153
Marketscan,NSAID,Osteoporotic fracture,Clinical vertebral fracture,2771,3590,24 months,45,1.2534818942
Marketscan,NSAID,Osteoporotic fracture,Clinical vertebral fracture,2771,3590,36 months,48,1.3370473538
Marketscan,NSAID,Osteoporotic fracture,Clinical vertebral fracture,2771,3590,AS cohort entry to exposure,23,0.6406685237
Marketscan,NSAID,Osteoporotic fracture,Non-vertebral osteoporotic fracture,2771,3590,12 months,61,1.6991643454
Marketscan,NSAID,Osteoporotic fracture,Non-vertebral osteoporotic fracture,2771,3590,24 months,78,2.1727019499
Marketscan,NSAID,Osteoporotic fracture,Non-vertebral osteoporotic fracture,2771,3590,36 months,86,2.3955431755
Marketscan,NSAID,Osteoporotic fracture,Non-vertebral osteoporotic fracture,2771,3590,AS cohort entry to exposure,62,1.7270194986
Marketscan,NSAID,PsO/PsA,Psoriasis,2771,3590,12 months,95,2.6462395543
Marketscan,NSAID,PsO/PsA,Psoriasis,2771,3590,24 months,120,3.3426183844
Marketscan,NSAID,PsO/PsA,Psoriasis,2771,3590,36 months,135,3.7604456825
Marketscan,NSAID,PsO/PsA,Psoriasis,2771,3590,AS cohort entry to exposure,89,2.4791086351
Marketscan,NSAID,PsO/PsA,Psoriatic arthritis,2771,3590,12 months,114,3.1754874652
Marketscan,NSAID,PsO/PsA,Psoriatic arthritis,2771,3590,24 months,129,3.5933147632
Marketscan,NSAID,PsO/PsA,Psoriatic arthritis,2771,3590,36 months,141,3.9275766017
Marketscan,NSAID,PsO/PsA,Psoriatic arthritis,2771,3590,AS cohort entry to exposure,127,3.5376044568
Marketscan,NSAID,Uveitis,Uveitis,2771,3590,12 months,166,4.6239554318
Marketscan,NSAID,Uveitis,Uveitis,2771,3590,24 months,204,5.6824512535
Marketscan,NSAID,Uveitis,Uveitis,2771,3590,36 months,219,6.1002785515
Marketscan,NSAID,Uveitis,Uveitis,2771,3590,AS cohort entry to exposure,161,4.4846796657
Marketscan,No exposure,Cancer,Hematologic Cancer,4504,4504,12 months,27,0.5994671403
Marketscan,No exposure,Cancer,Hematologic Cancer,4504,4504,24 months,30,0.6660746004
Marketscan,No exposure,Cancer,Hematologic Cancer,4504,4504,36 months,33,0.7326820604
Marketscan,No exposure,Cancer,Hematologic Cancer,4504,4504,AS cohort entry to exposure,1,0.0222024867
Marketscan,No exposure,Cancer,Non Melanoma Skin Cancer,4504,4504,12 months,32,0.7104795737
Marketscan,No exposure,Cancer,Non Melanoma Skin Cancer,4504,4504,24 months,58,1.2877442274
Marketscan,No exposure,Cancer,Non Melanoma Skin Cancer,4504,4504,36 months,70,1.5541740675
Marketscan,No exposure,Cancer,Non Melanoma Skin Cancer,4504,4504,AS cohort entry to exposure,1,0.0222024867
Marketscan,No exposure,Cancer,Solid Cancer,4504,4504,12 months,139,3.0861456483
Marketscan,No exposure,Cancer,Solid Cancer,4504,4504,24 months,176,3.9076376554
Marketscan,No exposure,Cancer,Solid Cancer,4504,4504,36 months,199,4.418294849
Marketscan,No exposure,Cancer,Solid Cancer,4504,4504,AS cohort entry to exposure,6,0.1332149201
Marketscan,No exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,4504,4504,12 months,54,1.1989342806
Marketscan,No exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,4504,4504,24 months,72,1.5985790409
Marketscan,No exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,4504,4504,36 months,78,1.7317939609
Marketscan,No exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,4504,4504,AS cohort entry to exposure,5,0.1110124334
Marketscan,No exposure,Cardiac disease,Conduction Block,4504,4504,12 months,50,1.1101243339
Marketscan,No exposure,Cardiac disease,Conduction Block,4504,4504,24 months,75,1.6651865009
Marketscan,No exposure,Cardiac disease,Conduction Block,4504,4504,36 months,84,1.865008881
Marketscan,No exposure,Cardiac disease,Conduction Block,4504,4504,AS cohort entry to exposure,0,0
Marketscan,No exposure,Cardiac disease,Myocardial infarction,4504,4504,12 months,9,0.1998223801
Marketscan,No exposure,Cardiac disease,Myocardial infarction,4504,4504,24 months,18,0.3996447602
Marketscan,No exposure,Cardiac disease,Myocardial infarction,4504,4504,36 months,22,0.4884547069
Marketscan,No exposure,Cardiac disease,Myocardial infarction,4504,4504,AS cohort entry to exposure,1,0.0222024867
Marketscan,No exposure,Infection,Hospitalized infection,4504,4504,12 months,136,3.0195381883
Marketscan,No exposure,Infection,Hospitalized infection,4504,4504,24 months,211,4.6847246892
Marketscan,No exposure,Infection,Hospitalized infection,4504,4504,36 months,250,5.5506216696
Marketscan,No exposure,Infection,Hospitalized infection,4504,4504,AS cohort entry to exposure,1,0.0222024867
Marketscan,No exposure,Infection,Opportunistic infection,4504,4504,12 months,40,0.8880994671
Marketscan,No exposure,Infection,Opportunistic infection,4504,4504,24 months,52,1.1545293073
Marketscan,No exposure,Infection,Opportunistic infection,4504,4504,36 months,69,1.5319715808
Marketscan,No exposure,Infection,Opportunistic infection,4504,4504,AS cohort entry to exposure,2,0.0444049734
Marketscan,No exposure,Inflammatory bowel disease,Crohn’s Disease,4504,4504,12 months,226,5.0177619893
Marketscan,No exposure,Inflammatory bowel disease,Crohn’s Disease,4504,4504,24 months,264,5.8614564831
Marketscan,No exposure,Inflammatory bowel disease,Crohn’s Disease,4504,4504,36 months,281,6.2388987567
Marketscan,No exposure,Inflammatory bowel disease,Crohn’s Disease,4504,4504,AS cohort entry to exposure,58,1.2877442274
Marketscan,No exposure,Inflammatory bowel disease,Ulcerative Colitis,4504,4504,12 months,194,4.3072824156
Marketscan,No exposure,Inflammatory bowel disease,Ulcerative Colitis,4504,4504,24 months,228,5.0621669627
Marketscan,No exposure,Inflammatory bowel disease,Ulcerative Colitis,4504,4504,36 months,234,5.1953818828
Marketscan,No exposure,Inflammatory bowel disease,Ulcerative Colitis,4504,4504,AS cohort entry to exposure,32,0.7104795737
Marketscan,No exposure,Kidney disease,Amyloidosis,4504,4504,12 months,1,0.0222024867
Marketscan,No exposure,Kidney disease,Amyloidosis,4504,4504,24 months,2,0.0444049734
Marketscan,No exposure,Kidney disease,Amyloidosis,4504,4504,36 months,2,0.0444049734
Marketscan,No exposure,Kidney disease,Amyloidosis,4504,4504,AS cohort entry to exposure,0,0
Marketscan,No exposure,Kidney disease,IgA nephropathy,4504,4504,12 months,7,0.1554174067
Marketscan,No exposure,Kidney disease,IgA nephropathy,4504,4504,24 months,9,0.1998223801
Marketscan,No exposure,Kidney disease,IgA nephropathy,4504,4504,36 months,10,0.2220248668
Marketscan,No exposure,Kidney disease,IgA nephropathy,4504,4504,AS cohort entry to exposure,0,0
Marketscan,No exposure,Kidney disease,Nephrotic syndrome,4504,4504,12 months,2,0.0444049734
Marketscan,No exposure,Kidney disease,Nephrotic syndrome,4504,4504,24 months,2,0.0444049734
Marketscan,No exposure,Kidney disease,Nephrotic syndrome,4504,4504,36 months,2,0.0444049734
Marketscan,No exposure,Kidney disease,Nephrotic syndrome,4504,4504,AS cohort entry to exposure,0,0
Marketscan,No exposure,Lung disease,Interstitial lung disease,4504,4504,12 months,7,0.1554174067
Marketscan,No exposure,Lung disease,Interstitial lung disease,4504,4504,24 months,7,0.1554174067
Marketscan,No exposure,Lung disease,Interstitial lung disease,4504,4504,36 months,9,0.1998223801
Marketscan,No exposure,Lung disease,Interstitial lung disease,4504,4504,AS cohort entry to exposure,0,0
Marketscan,No exposure,Lung disease,Restrictive lung disease ,4504,4504,12 months,44,0.9769094139
Marketscan,No exposure,Lung disease,Restrictive lung disease ,4504,4504,24 months,63,1.3987566607
Marketscan,No exposure,Lung disease,Restrictive lung disease ,4504,4504,36 months,72,1.5985790409
Marketscan,No exposure,Lung disease,Restrictive lung disease ,4504,4504,AS cohort entry to exposure,1,0.0222024867
Marketscan,No exposure,Neurological Disease,Cauda Equina syndrome,4504,4504,12 months,2,0.0444049734
Marketscan,No exposure,Neurological Disease,Cauda Equina syndrome,4504,4504,24 months,4,0.0888099467
Marketscan,No exposure,Neurological Disease,Cauda Equina syndrome,4504,4504,36 months,4,0.0888099467
Marketscan,No exposure,Neurological Disease,Cauda Equina syndrome,4504,4504,AS cohort entry to exposure,1,0.0222024867
Marketscan,No exposure,Neurological Disease,Spinal Cord compression,4504,4504,12 months,3,0.06660746
Marketscan,No exposure,Neurological Disease,Spinal Cord compression,4504,4504,24 months,7,0.1554174067
Marketscan,No exposure,Neurological Disease,Spinal Cord compression,4504,4504,36 months,8,0.1776198934
Marketscan,No exposure,Neurological Disease,Spinal Cord compression,4504,4504,AS cohort entry to exposure,0,0
Marketscan,No exposure,Osteoporotic fracture,Clinical vertebral fracture,4504,4504,12 months,38,0.8436944938
Marketscan,No exposure,Osteoporotic fracture,Clinical vertebral fracture,4504,4504,24 months,64,1.4209591474
Marketscan,No exposure,Osteoporotic fracture,Clinical vertebral fracture,4504,4504,36 months,75,1.6651865009
Marketscan,No exposure,Osteoporotic fracture,Clinical vertebral fracture,4504,4504,AS cohort entry to exposure,3,0.06660746
Marketscan,No exposure,Osteoporotic fracture,Non-vertebral osteoporotic fracture,4504,4504,12 months,47,1.0435168739
Marketscan,No exposure,Osteoporotic fracture,Non-vertebral osteoporotic fracture,4504,4504,24 months,84,1.865008881
Marketscan,No exposure,Osteoporotic fracture,Non-vertebral osteoporotic fracture,4504,4504,36 months,102,2.2646536412
Marketscan,No exposure,Osteoporotic fracture,Non-vertebral osteoporotic fracture,4504,4504,AS cohort entry to exposure,0,0
Marketscan,No exposure,PsO/PsA,Psoriasis,4504,4504,12 months,139,3.0861456483
Marketscan,No exposure,PsO/PsA,Psoriasis,4504,4504,24 months,167,3.7078152753
Marketscan,No exposure,PsO/PsA,Psoriasis,4504,4504,36 months,177,3.9298401421
Marketscan,No exposure,PsO/PsA,Psoriasis,4504,4504,AS cohort entry to exposure,30,0.6660746004
Marketscan,No exposure,PsO/PsA,Psoriatic arthritis,4504,4504,12 months,177,3.9298401421
Marketscan,No exposure,PsO/PsA,Psoriatic arthritis,4504,4504,24 months,209,4.6403197158
Marketscan,No exposure,PsO/PsA,Psoriatic arthritis,4504,4504,36 months,230,5.1065719361
Marketscan,No exposure,PsO/PsA,Psoriatic arthritis,4504,4504,AS cohort entry to exposure,63,1.3987566607
Marketscan,No exposure,Uveitis,Uveitis,4504,4504,12 months,306,6.7939609236
Marketscan,No exposure,Uveitis,Uveitis,4504,4504,24 months,368,8.1705150977
Marketscan,No exposure,Uveitis,Uveitis,4504,4504,36 months,390,8.6589698046
Marketscan,No exposure,Uveitis,Uveitis,4504,4504,AS cohort entry to exposure,73,1.6207815275
Marketscan,TNF,Cancer,Hematologic Cancer,3436,4040,12 months,4,0.099009901
Marketscan,TNF,Cancer,Hematologic Cancer,3436,4040,24 months,8,0.198019802
Marketscan,TNF,Cancer,Hematologic Cancer,3436,4040,36 months,9,0.2227722772
Marketscan,TNF,Cancer,Hematologic Cancer,3436,4040,AS cohort entry to exposure,5,0.1237623762
Marketscan,TNF,Cancer,Non Melanoma Skin Cancer,3436,4040,12 months,19,0.4702970297
Marketscan,TNF,Cancer,Non Melanoma Skin Cancer,3436,4040,24 months,39,0.9653465347
Marketscan,TNF,Cancer,Non Melanoma Skin Cancer,3436,4040,36 months,46,1.1386138614
Marketscan,TNF,Cancer,Non Melanoma Skin Cancer,3436,4040,AS cohort entry to exposure,21,0.5198019802
Marketscan,TNF,Cancer,Solid Cancer,3436,4040,12 months,75,1.8564356436
Marketscan,TNF,Cancer,Solid Cancer,3436,4040,24 months,99,2.4504950495
Marketscan,TNF,Cancer,Solid Cancer,3436,4040,36 months,108,2.6732673267
Marketscan,TNF,Cancer,Solid Cancer,3436,4040,AS cohort entry to exposure,48,1.1881188119
Marketscan,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,3436,4040,12 months,31,0.7673267327
Marketscan,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,3436,4040,24 months,40,0.9900990099
Marketscan,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,3436,4040,36 months,46,1.1386138614
Marketscan,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,3436,4040,AS cohort entry to exposure,23,0.5693069307
Marketscan,TNF,Cardiac disease,Conduction Block,3436,4040,12 months,21,0.5198019802
Marketscan,TNF,Cardiac disease,Conduction Block,3436,4040,24 months,32,0.7920792079
Marketscan,TNF,Cardiac disease,Conduction Block,3436,4040,36 months,38,0.9405940594
Marketscan,TNF,Cardiac disease,Conduction Block,3436,4040,AS cohort entry to exposure,17,0.4207920792
Marketscan,TNF,Cardiac disease,Myocardial infarction,3436,4040,12 months,6,0.1485148515
Marketscan,TNF,Cardiac disease,Myocardial infarction,3436,4040,24 months,15,0.3712871287
Marketscan,TNF,Cardiac disease,Myocardial infarction,3436,4040,36 months,18,0.4455445545
Marketscan,TNF,Cardiac disease,Myocardial infarction,3436,4040,AS cohort entry to exposure,5,0.1237623762
Marketscan,TNF,Infection,Hospitalized infection,3436,4040,12 months,111,2.7475247525
Marketscan,TNF,Infection,Hospitalized infection,3436,4040,24 months,164,4.0594059406
Marketscan,TNF,Infection,Hospitalized infection,3436,4040,36 months,190,4.702970297
Marketscan,TNF,Infection,Hospitalized infection,3436,4040,AS cohort entry to exposure,94,2.3267326733
Marketscan,TNF,Infection,Opportunistic infection,3436,4040,12 months,32,0.7920792079
Marketscan,TNF,Infection,Opportunistic infection,3436,4040,24 months,46,1.1386138614
Marketscan,TNF,Infection,Opportunistic infection,3436,4040,36 months,54,1.3366336634
Marketscan,TNF,Infection,Opportunistic infection,3436,4040,AS cohort entry to exposure,37,0.9158415842
Marketscan,TNF,Inflammatory bowel disease,Crohn’s Disease,3436,4040,12 months,214,5.297029703
Marketscan,TNF,Inflammatory bowel disease,Crohn’s Disease,3436,4040,24 months,240,5.9405940594
Marketscan,TNF,Inflammatory bowel disease,Crohn’s Disease,3436,4040,36 months,246,6.0891089109
Marketscan,TNF,Inflammatory bowel disease,Crohn’s Disease,3436,4040,AS cohort entry to exposure,185,4.5792079208
Marketscan,TNF,Inflammatory bowel disease,Ulcerative Colitis,3436,4040,12 months,143,3.5396039604
Marketscan,TNF,Inflammatory bowel disease,Ulcerative Colitis,3436,4040,24 months,164,4.0594059406
Marketscan,TNF,Inflammatory bowel disease,Ulcerative Colitis,3436,4040,36 months,174,4.3069306931
Marketscan,TNF,Inflammatory bowel disease,Ulcerative Colitis,3436,4040,AS cohort entry to exposure,107,2.6485148515
Marketscan,TNF,Kidney disease,Amyloidosis,3436,4040,12 months,2,0.0495049505
Marketscan,TNF,Kidney disease,Amyloidosis,3436,4040,24 months,3,0.0742574257
Marketscan,TNF,Kidney disease,Amyloidosis,3436,4040,36 months,3,0.0742574257
Marketscan,TNF,Kidney disease,Amyloidosis,3436,4040,AS cohort entry to exposure,0,0
Marketscan,TNF,Kidney disease,IgA nephropathy,3436,4040,12 months,4,0.099009901
Marketscan,TNF,Kidney disease,IgA nephropathy,3436,4040,24 months,5,0.1237623762
Marketscan,TNF,Kidney disease,IgA nephropathy,3436,4040,36 months,6,0.1485148515
Marketscan,TNF,Kidney disease,IgA nephropathy,3436,4040,AS cohort entry to exposure,3,0.0742574257
Marketscan,TNF,Kidney disease,Nephrotic syndrome,3436,4040,12 months,3,0.0742574257
Marketscan,TNF,Kidney disease,Nephrotic syndrome,3436,4040,24 months,5,0.1237623762
Marketscan,TNF,Kidney disease,Nephrotic syndrome,3436,4040,36 months,5,0.1237623762
Marketscan,TNF,Kidney disease,Nephrotic syndrome,3436,4040,AS cohort entry to exposure,2,0.0495049505
Marketscan,TNF,Lung disease,Interstitial lung disease,3436,4040,12 months,2,0.0495049505
Marketscan,TNF,Lung disease,Interstitial lung disease,3436,4040,24 months,3,0.0742574257
Marketscan,TNF,Lung disease,Interstitial lung disease,3436,4040,36 months,3,0.0742574257
Marketscan,TNF,Lung disease,Interstitial lung disease,3436,4040,AS cohort entry to exposure,1,0.0247524752
Marketscan,TNF,Lung disease,Restrictive lung disease ,3436,4040,12 months,26,0.6435643564
Marketscan,TNF,Lung disease,Restrictive lung disease ,3436,4040,24 months,42,1.0396039604
Marketscan,TNF,Lung disease,Restrictive lung disease ,3436,4040,36 months,48,1.1881188119
Marketscan,TNF,Lung disease,Restrictive lung disease ,3436,4040,AS cohort entry to exposure,21,0.5198019802
Marketscan,TNF,Neurological Disease,Cauda Equina syndrome,3436,4040,12 months,0,0
Marketscan,TNF,Neurological Disease,Cauda Equina syndrome,3436,4040,24 months,1,0.0247524752
Marketscan,TNF,Neurological Disease,Cauda Equina syndrome,3436,4040,36 months,1,0.0247524752
Marketscan,TNF,Neurological Disease,Cauda Equina syndrome,3436,4040,AS cohort entry to exposure,0,0
Marketscan,TNF,Neurological Disease,Spinal Cord compression,3436,4040,12 months,6,0.1485148515
Marketscan,TNF,Neurological Disease,Spinal Cord compression,3436,4040,24 months,11,0.2722772277
Marketscan,TNF,Neurological Disease,Spinal Cord compression,3436,4040,36 months,17,0.4207920792
Marketscan,TNF,Neurological Disease,Spinal Cord compression,3436,4040,AS cohort entry to exposure,3,0.0742574257
Marketscan,TNF,Osteoporotic fracture,Clinical vertebral fracture,3436,4040,12 months,19,0.4702970297
Marketscan,TNF,Osteoporotic fracture,Clinical vertebral fracture,3436,4040,24 months,30,0.7425742574
Marketscan,TNF,Osteoporotic fracture,Clinical vertebral fracture,3436,4040,36 months,32,0.7920792079
Marketscan,TNF,Osteoporotic fracture,Clinical vertebral fracture,3436,4040,AS cohort entry to exposure,8,0.198019802
Marketscan,TNF,Osteoporotic fracture,Non-vertebral osteoporotic fracture,3436,4040,12 months,35,0.8663366337
Marketscan,TNF,Osteoporotic fracture,Non-vertebral osteoporotic fracture,3436,4040,24 months,65,1.6089108911
Marketscan,TNF,Osteoporotic fracture,Non-vertebral osteoporotic fracture,3436,4040,36 months,76,1.8811881188
Marketscan,TNF,Osteoporotic fracture,Non-vertebral osteoporotic fracture,3436,4040,AS cohort entry to exposure,33,0.8168316832
Marketscan,TNF,PsO/PsA,Psoriasis,3436,4040,12 months,197,4.8762376238
Marketscan,TNF,PsO/PsA,Psoriasis,3436,4040,24 months,248,6.1386138614
Marketscan,TNF,PsO/PsA,Psoriasis,3436,4040,36 months,280,6.9306930693
Marketscan,TNF,PsO/PsA,Psoriasis,3436,4040,AS cohort entry to exposure,157,3.8861386139
Marketscan,TNF,PsO/PsA,Psoriatic arthritis,3436,4040,12 months,352,8.7128712871
Marketscan,TNF,PsO/PsA,Psoriatic arthritis,3436,4040,24 months,406,10.04950495
Marketscan,TNF,PsO/PsA,Psoriatic arthritis,3436,4040,36 months,425,10.51980198
Marketscan,TNF,PsO/PsA,Psoriatic arthritis,3436,4040,AS cohort entry to exposure,294,7.2772277228
Marketscan,TNF,Uveitis,Uveitis,3436,4040,12 months,286,7.0792079208
Marketscan,TNF,Uveitis,Uveitis,3436,4040,24 months,346,8.5643564356
Marketscan,TNF,Uveitis,Uveitis,3436,4040,36 months,370,9.1584158416
Marketscan,TNF,Uveitis,Uveitis,3436,4040,AS cohort entry to exposure,234,5.7920792079
Medicare,DMARD,Cancer,Hematologic Cancer,1681,2034,12 months,40,1.9665683382
Medicare,DMARD,Cancer,Hematologic Cancer,1681,2034,24 months,54,2.6548672566
Medicare,DMARD,Cancer,Hematologic Cancer,1681,2034,36 months,56,2.7531956735
Medicare,DMARD,Cancer,Hematologic Cancer,1681,2034,AS cohort entry to exposure,37,1.8190757129
Medicare,DMARD,Cancer,Non Melanoma Skin Cancer,1681,2034,12 months,45,2.2123893805
Medicare,DMARD,Cancer,Non Melanoma Skin Cancer,1681,2034,24 months,74,3.6381514258
Medicare,DMARD,Cancer,Non Melanoma Skin Cancer,1681,2034,36 months,105,5.1622418879
Medicare,DMARD,Cancer,Non Melanoma Skin Cancer,1681,2034,AS cohort entry to exposure,50,2.4582104228
Medicare,DMARD,Cancer,Solid Cancer,1681,2034,12 months,218,10.717797443
Medicare,DMARD,Cancer,Solid Cancer,1681,2034,24 months,280,13.765978368
Medicare,DMARD,Cancer,Solid Cancer,1681,2034,36 months,315,15.486725664
Medicare,DMARD,Cancer,Solid Cancer,1681,2034,AS cohort entry to exposure,222,10.914454277
Medicare,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1681,2034,12 months,118,5.8013765978
Medicare,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1681,2034,24 months,170,8.3579154376
Medicare,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1681,2034,36 months,197,9.6853490659
Medicare,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1681,2034,AS cohort entry to exposure,129,6.3421828909
Medicare,DMARD,Cardiac disease,Conduction Block,1681,2034,12 months,83,4.0806293019
Medicare,DMARD,Cardiac disease,Conduction Block,1681,2034,24 months,130,6.3913470993
Medicare,DMARD,Cardiac disease,Conduction Block,1681,2034,36 months,169,8.3087512291
Medicare,DMARD,Cardiac disease,Conduction Block,1681,2034,AS cohort entry to exposure,82,4.0314650934
Medicare,DMARD,Cardiac disease,Myocardial infarction,1681,2034,12 months,28,1.3765978368
Medicare,DMARD,Cardiac disease,Myocardial infarction,1681,2034,24 months,57,2.802359882
Medicare,DMARD,Cardiac disease,Myocardial infarction,1681,2034,36 months,71,3.4906588004
Medicare,DMARD,Cardiac disease,Myocardial infarction,1681,2034,AS cohort entry to exposure,29,1.4257620452
Medicare,DMARD,Infection,Hospitalized infection,1681,2034,12 months,273,13.421828909
Medicare,DMARD,Infection,Hospitalized infection,1681,2034,24 months,434,21.33726647
Medicare,DMARD,Infection,Hospitalized infection,1681,2034,36 months,548,26.941986234
Medicare,DMARD,Infection,Hospitalized infection,1681,2034,AS cohort entry to exposure,317,15.585054081
Medicare,DMARD,Infection,Opportunistic infection,1681,2034,12 months,54,2.6548672566
Medicare,DMARD,Infection,Opportunistic infection,1681,2034,24 months,86,4.2281219272
Medicare,DMARD,Infection,Opportunistic infection,1681,2034,36 months,101,4.9655850541
Medicare,DMARD,Infection,Opportunistic infection,1681,2034,AS cohort entry to exposure,67,3.2940019666
Medicare,DMARD,Inflammatory bowel disease,Crohn’s Disease,1681,2034,12 months,45,2.2123893805
Medicare,DMARD,Inflammatory bowel disease,Crohn’s Disease,1681,2034,24 months,54,2.6548672566
Medicare,DMARD,Inflammatory bowel disease,Crohn’s Disease,1681,2034,36 months,61,2.9990167158
Medicare,DMARD,Inflammatory bowel disease,Crohn’s Disease,1681,2034,AS cohort entry to exposure,38,1.8682399213
Medicare,DMARD,Inflammatory bowel disease,Ulcerative Colitis,1681,2034,12 months,56,2.7531956735
Medicare,DMARD,Inflammatory bowel disease,Ulcerative Colitis,1681,2034,24 months,76,3.7364798427
Medicare,DMARD,Inflammatory bowel disease,Ulcerative Colitis,1681,2034,36 months,80,3.9331366765
Medicare,DMARD,Inflammatory bowel disease,Ulcerative Colitis,1681,2034,AS cohort entry to exposure,66,3.2448377581
Medicare,DMARD,Kidney disease,Amyloidosis,1681,2034,12 months,1,0.0491642085
Medicare,DMARD,Kidney disease,Amyloidosis,1681,2034,24 months,1,0.0491642085
Medicare,DMARD,Kidney disease,Amyloidosis,1681,2034,36 months,1,0.0491642085
Medicare,DMARD,Kidney disease,Amyloidosis,1681,2034,AS cohort entry to exposure,1,0.0491642085
Medicare,DMARD,Kidney disease,IgA nephropathy,1681,2034,12 months,2,0.0983284169
Medicare,DMARD,Kidney disease,IgA nephropathy,1681,2034,24 months,5,0.2458210423
Medicare,DMARD,Kidney disease,IgA nephropathy,1681,2034,36 months,7,0.3441494592
Medicare,DMARD,Kidney disease,IgA nephropathy,1681,2034,AS cohort entry to exposure,5,0.2458210423
Medicare,DMARD,Kidney disease,Nephrotic syndrome,1681,2034,12 months,4,0.1966568338
Medicare,DMARD,Kidney disease,Nephrotic syndrome,1681,2034,24 months,5,0.2458210423
Medicare,DMARD,Kidney disease,Nephrotic syndrome,1681,2034,36 months,6,0.2949852507
Medicare,DMARD,Kidney disease,Nephrotic syndrome,1681,2034,AS cohort entry to exposure,3,0.1474926254
Medicare,DMARD,Lung disease,Apical Pulmonary fibrosis,1681,2034,12 months,0,0
Medicare,DMARD,Lung disease,Apical Pulmonary fibrosis,1681,2034,24 months,1,0.0491642085
Medicare,DMARD,Lung disease,Apical Pulmonary fibrosis,1681,2034,36 months,2,0.0983284169
Medicare,DMARD,Lung disease,Apical Pulmonary fibrosis,1681,2034,AS cohort entry to exposure,1,0.0491642085
Medicare,DMARD,Lung disease,Interstitial lung disease,1681,2034,12 months,19,0.9341199607
Medicare,DMARD,Lung disease,Interstitial lung disease,1681,2034,24 months,29,1.4257620452
Medicare,DMARD,Lung disease,Interstitial lung disease,1681,2034,36 months,40,1.9665683382
Medicare,DMARD,Lung disease,Interstitial lung disease,1681,2034,AS cohort entry to exposure,23,1.1307767945
Medicare,DMARD,Lung disease,Restrictive lung disease ,1681,2034,12 months,77,3.7856440511
Medicare,DMARD,Lung disease,Restrictive lung disease ,1681,2034,24 months,112,5.5063913471
Medicare,DMARD,Lung disease,Restrictive lung disease ,1681,2034,36 months,142,6.9813176008
Medicare,DMARD,Lung disease,Restrictive lung disease ,1681,2034,AS cohort entry to exposure,93,4.5722713864
Medicare,DMARD,Neurological Disease,Cauda Equina syndrome,1681,2034,12 months,2,0.0983284169
Medicare,DMARD,Neurological Disease,Cauda Equina syndrome,1681,2034,24 months,4,0.1966568338
Medicare,DMARD,Neurological Disease,Cauda Equina syndrome,1681,2034,36 months,4,0.1966568338
Medicare,DMARD,Neurological Disease,Cauda Equina syndrome,1681,2034,AS cohort entry to exposure,0,0
Medicare,DMARD,Neurological Disease,Spinal Cord compression,1681,2034,12 months,2,0.0983284169
Medicare,DMARD,Neurological Disease,Spinal Cord compression,1681,2034,24 months,5,0.2458210423
Medicare,DMARD,Neurological Disease,Spinal Cord compression,1681,2034,36 months,8,0.3933136676
Medicare,DMARD,Neurological Disease,Spinal Cord compression,1681,2034,AS cohort entry to exposure,3,0.1474926254
Medicare,DMARD,Osteoporotic fracture,Clinical vertebral fracture,1681,2034,12 months,70,3.4414945919
Medicare,DMARD,Osteoporotic fracture,Clinical vertebral fracture,1681,2034,24 months,115,5.6538839725
Medicare,DMARD,Osteoporotic fracture,Clinical vertebral fracture,1681,2034,36 months,153,7.5221238938
Medicare,DMARD,Osteoporotic fracture,Clinical vertebral fracture,1681,2034,AS cohort entry to exposure,103,5.063913471
Medicare,DMARD,Osteoporotic fracture,Non-vertebral osteoporotic fracture,1681,2034,12 months,83,4.0806293019
Medicare,DMARD,Osteoporotic fracture,Non-vertebral osteoporotic fracture,1681,2034,24 months,146,7.1779744346
Medicare,DMARD,Osteoporotic fracture,Non-vertebral osteoporotic fracture,1681,2034,36 months,184,9.0462143559
Medicare,DMARD,Osteoporotic fracture,Non-vertebral osteoporotic fracture,1681,2034,AS cohort entry to exposure,114,5.604719764
Medicare,DMARD,PsO/PsA,Psoriasis,1681,2034,12 months,90,4.4247787611
Medicare,DMARD,PsO/PsA,Psoriasis,1681,2034,24 months,119,5.8505408063
Medicare,DMARD,PsO/PsA,Psoriasis,1681,2034,36 months,138,6.784660767
Medicare,DMARD,PsO/PsA,Psoriasis,1681,2034,AS cohort entry to exposure,96,4.7197640118
Medicare,DMARD,PsO/PsA,Psoriatic arthritis,1681,2034,12 months,148,7.2763028515
Medicare,DMARD,PsO/PsA,Psoriatic arthritis,1681,2034,24 months,169,8.3087512291
Medicare,DMARD,PsO/PsA,Psoriatic arthritis,1681,2034,36 months,185,9.0953785644
Medicare,DMARD,PsO/PsA,Psoriatic arthritis,1681,2034,AS cohort entry to exposure,140,6.8829891839
Medicare,DMARD,Uveitis,Uveitis,1681,2034,12 months,61,2.9990167158
Medicare,DMARD,Uveitis,Uveitis,1681,2034,24 months,67,3.2940019666
Medicare,DMARD,Uveitis,Uveitis,1681,2034,36 months,75,3.6873156342
Medicare,DMARD,Uveitis,Uveitis,1681,2034,AS cohort entry to exposure,60,2.9498525074
Medicare,NSAID,Cancer,Hematologic Cancer,4436,6608,12 months,130,1.9673123487
Medicare,NSAID,Cancer,Hematologic Cancer,4436,6608,24 months,155,2.3456416465
Medicare,NSAID,Cancer,Hematologic Cancer,4436,6608,36 months,172,2.602905569
Medicare,NSAID,Cancer,Hematologic Cancer,4436,6608,AS cohort entry to exposure,144,2.1791767554
Medicare,NSAID,Cancer,Non Melanoma Skin Cancer,4436,6608,12 months,167,2.5272397094
Medicare,NSAID,Cancer,Non Melanoma Skin Cancer,4436,6608,24 months,268,4.0556900726
Medicare,NSAID,Cancer,Non Melanoma Skin Cancer,4436,6608,36 months,350,5.2966101695
Medicare,NSAID,Cancer,Non Melanoma Skin Cancer,4436,6608,AS cohort entry to exposure,180,2.7239709443
Medicare,NSAID,Cancer,Solid Cancer,4436,6608,12 months,846,12.802663438
Medicare,NSAID,Cancer,Solid Cancer,4436,6608,24 months,1037,15.693099274
Medicare,NSAID,Cancer,Solid Cancer,4436,6608,36 months,1136,17.191283293
Medicare,NSAID,Cancer,Solid Cancer,4436,6608,AS cohort entry to exposure,980,14.830508475
Medicare,NSAID,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,4436,6608,12 months,435,6.5829297821
Medicare,NSAID,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,4436,6608,24 months,611,9.2463680387
Medicare,NSAID,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,4436,6608,36 months,725,10.971549637
Medicare,NSAID,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,4436,6608,AS cohort entry to exposure,556,8.4140435835
Medicare,NSAID,Cardiac disease,Conduction Block,4436,6608,12 months,285,4.3129539952
Medicare,NSAID,Cardiac disease,Conduction Block,4436,6608,24 months,422,6.3861985472
Medicare,NSAID,Cardiac disease,Conduction Block,4436,6608,36 months,535,8.0962469734
Medicare,NSAID,Cardiac disease,Conduction Block,4436,6608,AS cohort entry to exposure,431,6.5223970944
Medicare,NSAID,Cardiac disease,Myocardial infarction,4436,6608,12 months,76,1.1501210654
Medicare,NSAID,Cardiac disease,Myocardial infarction,4436,6608,24 months,150,2.2699757869
Medicare,NSAID,Cardiac disease,Myocardial infarction,4436,6608,36 months,209,3.1628329298
Medicare,NSAID,Cardiac disease,Myocardial infarction,4436,6608,AS cohort entry to exposure,137,2.0732445521
Medicare,NSAID,Infection,Hospitalized infection,4436,6608,12 months,896,13.559322034
Medicare,NSAID,Infection,Hospitalized infection,4436,6608,24 months,1396,21.12590799
Medicare,NSAID,Infection,Hospitalized infection,4436,6608,36 months,1727,26.134987893
Medicare,NSAID,Infection,Hospitalized infection,4436,6608,AS cohort entry to exposure,1284,19.430992736
Medicare,NSAID,Infection,Opportunistic infection,4436,6608,12 months,119,1.8008474576
Medicare,NSAID,Infection,Opportunistic infection,4436,6608,24 months,193,2.9207021792
Medicare,NSAID,Infection,Opportunistic infection,4436,6608,36 months,256,3.8740920097
Medicare,NSAID,Infection,Opportunistic infection,4436,6608,AS cohort entry to exposure,218,3.299031477
Medicare,NSAID,Inflammatory bowel disease,Crohn’s Disease,4436,6608,12 months,97,1.4679176755
Medicare,NSAID,Inflammatory bowel disease,Crohn’s Disease,4436,6608,24 months,121,1.8311138015
Medicare,NSAID,Inflammatory bowel disease,Crohn’s Disease,4436,6608,36 months,137,2.0732445521
Medicare,NSAID,Inflammatory bowel disease,Crohn’s Disease,4436,6608,AS cohort entry to exposure,120,1.8159806295
Medicare,NSAID,Inflammatory bowel disease,Ulcerative Colitis,4436,6608,12 months,85,1.2863196126
Medicare,NSAID,Inflammatory bowel disease,Ulcerative Colitis,4436,6608,24 months,118,1.7857142857
Medicare,NSAID,Inflammatory bowel disease,Ulcerative Colitis,4436,6608,36 months,146,2.2094430993
Medicare,NSAID,Inflammatory bowel disease,Ulcerative Colitis,4436,6608,AS cohort entry to exposure,129,1.9521791768
Medicare,NSAID,Kidney disease,Amyloidosis,4436,6608,12 months,3,0.0453995157
Medicare,NSAID,Kidney disease,Amyloidosis,4436,6608,24 months,4,0.0605326877
Medicare,NSAID,Kidney disease,Amyloidosis,4436,6608,36 months,4,0.0605326877
Medicare,NSAID,Kidney disease,Amyloidosis,4436,6608,AS cohort entry to exposure,4,0.0605326877
Medicare,NSAID,Kidney disease,IgA nephropathy,4436,6608,12 months,7,0.1059322034
Medicare,NSAID,Kidney disease,IgA nephropathy,4436,6608,24 months,9,0.1361985472
Medicare,NSAID,Kidney disease,IgA nephropathy,4436,6608,36 months,9,0.1361985472
Medicare,NSAID,Kidney disease,IgA nephropathy,4436,6608,AS cohort entry to exposure,11,0.166464891
Medicare,NSAID,Kidney disease,Nephrotic syndrome,4436,6608,12 months,4,0.0605326877
Medicare,NSAID,Kidney disease,Nephrotic syndrome,4436,6608,24 months,6,0.0907990315
Medicare,NSAID,Kidney disease,Nephrotic syndrome,4436,6608,36 months,6,0.0907990315
Medicare,NSAID,Kidney disease,Nephrotic syndrome,4436,6608,AS cohort entry to exposure,4,0.0605326877
Medicare,NSAID,Lung disease,Interstitial lung disease,4436,6608,12 months,32,0.4842615012
Medicare,NSAID,Lung disease,Interstitial lung disease,4436,6608,24 months,38,0.5750605327
Medicare,NSAID,Lung disease,Interstitial lung disease,4436,6608,36 months,43,0.6507263923
Medicare,NSAID,Lung disease,Interstitial lung disease,4436,6608,AS cohort entry to exposure,38,0.5750605327
Medicare,NSAID,Lung disease,Restrictive lung disease ,4436,6608,12 months,198,2.9963680387
Medicare,NSAID,Lung disease,Restrictive lung disease ,4436,6608,24 months,311,4.7064164649
Medicare,NSAID,Lung disease,Restrictive lung disease ,4436,6608,36 months,374,5.6598062954
Medicare,NSAID,Lung disease,Restrictive lung disease ,4436,6608,AS cohort entry to exposure,331,5.0090799031
Medicare,NSAID,Neurological Disease,Cauda Equina syndrome,4436,6608,12 months,4,0.0605326877
Medicare,NSAID,Neurological Disease,Cauda Equina syndrome,4436,6608,24 months,10,0.1513317191
Medicare,NSAID,Neurological Disease,Cauda Equina syndrome,4436,6608,36 months,11,0.166464891
Medicare,NSAID,Neurological Disease,Cauda Equina syndrome,4436,6608,AS cohort entry to exposure,4,0.0605326877
Medicare,NSAID,Neurological Disease,Spinal Cord compression,4436,6608,12 months,15,0.2269975787
Medicare,NSAID,Neurological Disease,Spinal Cord compression,4436,6608,24 months,22,0.3329297821
Medicare,NSAID,Neurological Disease,Spinal Cord compression,4436,6608,36 months,34,0.514527845
Medicare,NSAID,Neurological Disease,Spinal Cord compression,4436,6608,AS cohort entry to exposure,21,0.3177966102
Medicare,NSAID,Osteoporotic fracture,Clinical vertebral fracture,4436,6608,12 months,330,4.9939467312
Medicare,NSAID,Osteoporotic fracture,Clinical vertebral fracture,4436,6608,24 months,502,7.5968523002
Medicare,NSAID,Osteoporotic fracture,Clinical vertebral fracture,4436,6608,36 months,618,9.3523002421
Medicare,NSAID,Osteoporotic fracture,Clinical vertebral fracture,4436,6608,AS cohort entry to exposure,481,7.2790556901
Medicare,NSAID,Osteoporotic fracture,Non-vertebral osteoporotic fracture,4436,6608,12 months,402,6.083535109
Medicare,NSAID,Osteoporotic fracture,Non-vertebral osteoporotic fracture,4436,6608,24 months,616,9.3220338983
Medicare,NSAID,Osteoporotic fracture,Non-vertebral osteoporotic fracture,4436,6608,36 months,765,11.576876513
Medicare,NSAID,Osteoporotic fracture,Non-vertebral osteoporotic fracture,4436,6608,AS cohort entry to exposure,637,9.6398305085
Medicare,NSAID,PsO/PsA,Psoriasis,4436,6608,12 months,167,2.5272397094
Medicare,NSAID,PsO/PsA,Psoriasis,4436,6608,24 months,232,3.5108958838
Medicare,NSAID,PsO/PsA,Psoriasis,4436,6608,36 months,272,4.1162227603
Medicare,NSAID,PsO/PsA,Psoriasis,4436,6608,AS cohort entry to exposure,283,4.2826876513
Medicare,NSAID,PsO/PsA,Psoriatic arthritis,4436,6608,12 months,142,2.1489104116
Medicare,NSAID,PsO/PsA,Psoriatic arthritis,4436,6608,24 months,166,2.5121065375
Medicare,NSAID,PsO/PsA,Psoriatic arthritis,4436,6608,36 months,181,2.7391041162
Medicare,NSAID,PsO/PsA,Psoriatic arthritis,4436,6608,AS cohort entry to exposure,199,3.0115012107
Medicare,NSAID,Uveitis,Uveitis,4436,6608,12 months,92,1.392251816
Medicare,NSAID,Uveitis,Uveitis,4436,6608,24 months,123,1.8613801453
Medicare,NSAID,Uveitis,Uveitis,4436,6608,36 months,138,2.088377724
Medicare,NSAID,Uveitis,Uveitis,4436,6608,AS cohort entry to exposure,145,2.1943099274
Medicare,No exposure,Cancer,Hematologic Cancer,5999,5999,12 months,104,1.7336222704
Medicare,No exposure,Cancer,Hematologic Cancer,5999,5999,24 months,127,2.1170195033
Medicare,No exposure,Cancer,Hematologic Cancer,5999,5999,36 months,150,2.5004167361
Medicare,No exposure,Cancer,Hematologic Cancer,5999,5999,AS cohort entry to exposure,4,0.0666777796
Medicare,No exposure,Cancer,Non Melanoma Skin Cancer,5999,5999,12 months,132,2.2003667278
Medicare,No exposure,Cancer,Non Melanoma Skin Cancer,5999,5999,24 months,220,3.6672778796
Medicare,No exposure,Cancer,Non Melanoma Skin Cancer,5999,5999,36 months,282,4.7007834639
Medicare,No exposure,Cancer,Non Melanoma Skin Cancer,5999,5999,AS cohort entry to exposure,1,0.0166694449
Medicare,No exposure,Cancer,Solid Cancer,5999,5999,12 months,770,12.835472579
Medicare,No exposure,Cancer,Solid Cancer,5999,5999,24 months,950,15.835972662
Medicare,No exposure,Cancer,Solid Cancer,5999,5999,36 months,1077,17.952992165
Medicare,No exposure,Cancer,Solid Cancer,5999,5999,AS cohort entry to exposure,27,0.4500750125
Medicare,No exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,5999,5999,12 months,415,6.9178196366
Medicare,No exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,5999,5999,24 months,565,9.4182363727
Medicare,No exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,5999,5999,36 months,675,11.251875313
Medicare,No exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,5999,5999,AS cohort entry to exposure,7,0.1166861144
Medicare,No exposure,Cardiac disease,Conduction Block,5999,5999,12 months,237,3.9506584431
Medicare,No exposure,Cardiac disease,Conduction Block,5999,5999,24 months,410,6.8344724121
Medicare,No exposure,Cardiac disease,Conduction Block,5999,5999,36 months,514,8.5680946824
Medicare,No exposure,Cardiac disease,Conduction Block,5999,5999,AS cohort entry to exposure,0,0
Medicare,No exposure,Cardiac disease,Myocardial infarction,5999,5999,12 months,63,1.0501750292
Medicare,No exposure,Cardiac disease,Myocardial infarction,5999,5999,24 months,138,2.3003833972
Medicare,No exposure,Cardiac disease,Myocardial infarction,5999,5999,36 months,197,3.2838806468
Medicare,No exposure,Cardiac disease,Myocardial infarction,5999,5999,AS cohort entry to exposure,0,0
Medicare,No exposure,Infection,Hospitalized infection,5999,5999,12 months,663,11.051841974
Medicare,No exposure,Infection,Hospitalized infection,5999,5999,24 months,1185,19.753292215
Medicare,No exposure,Infection,Hospitalized infection,5999,5999,36 months,1548,25.804300717
Medicare,No exposure,Infection,Hospitalized infection,5999,5999,AS cohort entry to exposure,1,0.0166694449
Medicare,No exposure,Infection,Opportunistic infection,5999,5999,12 months,95,1.5835972662
Medicare,No exposure,Infection,Opportunistic infection,5999,5999,24 months,163,2.7171195199
Medicare,No exposure,Infection,Opportunistic infection,5999,5999,36 months,203,3.3838973162
Medicare,No exposure,Infection,Opportunistic infection,5999,5999,AS cohort entry to exposure,3,0.0500083347
Medicare,No exposure,Inflammatory bowel disease,Crohn’s Disease,5999,5999,12 months,126,2.1003500583
Medicare,No exposure,Inflammatory bowel disease,Crohn’s Disease,5999,5999,24 months,151,2.517086181
Medicare,No exposure,Inflammatory bowel disease,Crohn’s Disease,5999,5999,36 months,165,2.7504584097
Medicare,No exposure,Inflammatory bowel disease,Crohn’s Disease,5999,5999,AS cohort entry to exposure,24,0.4000666778
Medicare,No exposure,Inflammatory bowel disease,Ulcerative Colitis,5999,5999,12 months,107,1.7836306051
Medicare,No exposure,Inflammatory bowel disease,Ulcerative Colitis,5999,5999,24 months,147,2.4504084014
Medicare,No exposure,Inflammatory bowel disease,Ulcerative Colitis,5999,5999,36 months,172,2.8671445241
Medicare,No exposure,Inflammatory bowel disease,Ulcerative Colitis,5999,5999,AS cohort entry to exposure,14,0.2333722287
Medicare,No exposure,Kidney disease,Amyloidosis,5999,5999,12 months,4,0.0666777796
Medicare,No exposure,Kidney disease,Amyloidosis,5999,5999,24 months,6,0.1000166694
Medicare,No exposure,Kidney disease,Amyloidosis,5999,5999,36 months,8,0.1333555593
Medicare,No exposure,Kidney disease,Amyloidosis,5999,5999,AS cohort entry to exposure,0,0
Medicare,No exposure,Kidney disease,IgA nephropathy,5999,5999,12 months,6,0.1000166694
Medicare,No exposure,Kidney disease,IgA nephropathy,5999,5999,24 months,11,0.183363894
Medicare,No exposure,Kidney disease,IgA nephropathy,5999,5999,36 months,13,0.2167027838
Medicare,No exposure,Kidney disease,IgA nephropathy,5999,5999,AS cohort entry to exposure,0,0
Medicare,No exposure,Kidney disease,Nephrotic syndrome,5999,5999,12 months,7,0.1166861144
Medicare,No exposure,Kidney disease,Nephrotic syndrome,5999,5999,24 months,10,0.1666944491
Medicare,No exposure,Kidney disease,Nephrotic syndrome,5999,5999,36 months,11,0.183363894
Medicare,No exposure,Kidney disease,Nephrotic syndrome,5999,5999,AS cohort entry to exposure,0,0
Medicare,No exposure,Lung disease,Apical Pulmonary fibrosis,5999,5999,12 months,1,0.0166694449
Medicare,No exposure,Lung disease,Apical Pulmonary fibrosis,5999,5999,24 months,1,0.0166694449
Medicare,No exposure,Lung disease,Apical Pulmonary fibrosis,5999,5999,36 months,1,0.0166694449
Medicare,No exposure,Lung disease,Apical Pulmonary fibrosis,5999,5999,AS cohort entry to exposure,0,0
Medicare,No exposure,Lung disease,Interstitial lung disease,5999,5999,12 months,32,0.533422237
Medicare,No exposure,Lung disease,Interstitial lung disease,5999,5999,24 months,47,0.7834639107
Medicare,No exposure,Lung disease,Interstitial lung disease,5999,5999,36 months,53,0.8834805801
Medicare,No exposure,Lung disease,Interstitial lung disease,5999,5999,AS cohort entry to exposure,0,0
Medicare,No exposure,Lung disease,Restrictive lung disease ,5999,5999,12 months,195,3.250541757
Medicare,No exposure,Lung disease,Restrictive lung disease ,5999,5999,24 months,276,4.6007667945
Medicare,No exposure,Lung disease,Restrictive lung disease ,5999,5999,36 months,341,5.6842807135
Medicare,No exposure,Lung disease,Restrictive lung disease ,5999,5999,AS cohort entry to exposure,2,0.0333388898
Medicare,No exposure,Neurological Disease,Cauda Equina syndrome,5999,5999,12 months,7,0.1166861144
Medicare,No exposure,Neurological Disease,Cauda Equina syndrome,5999,5999,24 months,9,0.1500250042
Medicare,No exposure,Neurological Disease,Cauda Equina syndrome,5999,5999,36 months,11,0.183363894
Medicare,No exposure,Neurological Disease,Cauda Equina syndrome,5999,5999,AS cohort entry to exposure,1,0.0166694449
Medicare,No exposure,Neurological Disease,Spinal Cord compression,5999,5999,12 months,12,0.2000333389
Medicare,No exposure,Neurological Disease,Spinal Cord compression,5999,5999,24 months,17,0.2833805634
Medicare,No exposure,Neurological Disease,Spinal Cord compression,5999,5999,36 months,23,0.3833972329
Medicare,No exposure,Neurological Disease,Spinal Cord compression,5999,5999,AS cohort entry to exposure,0,0
Medicare,No exposure,Osteoporotic fracture,Clinical vertebral fracture,5999,5999,12 months,260,4.3340556759
Medicare,No exposure,Osteoporotic fracture,Clinical vertebral fracture,5999,5999,24 months,411,6.851141857
Medicare,No exposure,Osteoporotic fracture,Clinical vertebral fracture,5999,5999,36 months,525,8.7514585764
Medicare,No exposure,Osteoporotic fracture,Clinical vertebral fracture,5999,5999,AS cohort entry to exposure,16,0.2667111185
Medicare,No exposure,Osteoporotic fracture,Non-vertebral osteoporotic fracture,5999,5999,12 months,262,4.3673945658
Medicare,No exposure,Osteoporotic fracture,Non-vertebral osteoporotic fracture,5999,5999,24 months,455,7.5845974329
Medicare,No exposure,Osteoporotic fracture,Non-vertebral osteoporotic fracture,5999,5999,36 months,594,9.901650275
Medicare,No exposure,Osteoporotic fracture,Non-vertebral osteoporotic fracture,5999,5999,AS cohort entry to exposure,3,0.0500083347
Medicare,No exposure,PsO/PsA,Psoriasis,5999,5999,12 months,179,2.9838306384
Medicare,No exposure,PsO/PsA,Psoriasis,5999,5999,24 months,252,4.2007001167
Medicare,No exposure,PsO/PsA,Psoriasis,5999,5999,36 months,283,4.7174529088
Medicare,No exposure,PsO/PsA,Psoriasis,5999,5999,AS cohort entry to exposure,22,0.366727788
Medicare,No exposure,PsO/PsA,Psoriatic arthritis,5999,5999,12 months,172,2.8671445241
Medicare,No exposure,PsO/PsA,Psoriatic arthritis,5999,5999,24 months,204,3.4005667611
Medicare,No exposure,PsO/PsA,Psoriatic arthritis,5999,5999,36 months,220,3.6672778796
Medicare,No exposure,PsO/PsA,Psoriatic arthritis,5999,5999,AS cohort entry to exposure,51,0.8501416903
Medicare,No exposure,Uveitis,Uveitis,5999,5999,12 months,100,1.6669444907
Medicare,No exposure,Uveitis,Uveitis,5999,5999,24 months,137,2.2837139523
Medicare,No exposure,Uveitis,Uveitis,5999,5999,36 months,150,2.5004167361
Medicare,No exposure,Uveitis,Uveitis,5999,5999,AS cohort entry to exposure,12,0.2000333389
Medicare,TNF,Cancer,Hematologic Cancer,594,679,12 months,5,0.736377025
Medicare,TNF,Cancer,Hematologic Cancer,594,679,24 months,7,1.0309278351
Medicare,TNF,Cancer,Hematologic Cancer,594,679,36 months,10,1.4727540501
Medicare,TNF,Cancer,Hematologic Cancer,594,679,AS cohort entry to exposure,3,0.441826215
Medicare,TNF,Cancer,Non Melanoma Skin Cancer,594,679,12 months,12,1.7673048601
Medicare,TNF,Cancer,Non Melanoma Skin Cancer,594,679,24 months,19,2.7982326951
Medicare,TNF,Cancer,Non Melanoma Skin Cancer,594,679,36 months,27,3.9764359352
Medicare,TNF,Cancer,Non Melanoma Skin Cancer,594,679,AS cohort entry to exposure,15,2.2091310751
Medicare,TNF,Cancer,Solid Cancer,594,679,12 months,72,10.603829161
Medicare,TNF,Cancer,Solid Cancer,594,679,24 months,86,12.665684831
Medicare,TNF,Cancer,Solid Cancer,594,679,36 months,102,15.022091311
Medicare,TNF,Cancer,Solid Cancer,594,679,AS cohort entry to exposure,57,8.3946980854
Medicare,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,594,679,12 months,43,6.3328424153
Medicare,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,594,679,24 months,63,9.2783505155
Medicare,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,594,679,36 months,73,10.751104566
Medicare,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,594,679,AS cohort entry to exposure,40,5.8910162003
Medicare,TNF,Cardiac disease,Conduction Block,594,679,12 months,36,5.3019145803
Medicare,TNF,Cardiac disease,Conduction Block,594,679,24 months,48,7.0692194404
Medicare,TNF,Cardiac disease,Conduction Block,594,679,36 months,56,8.2474226804
Medicare,TNF,Cardiac disease,Conduction Block,594,679,AS cohort entry to exposure,29,4.2709867452
Medicare,TNF,Cardiac disease,Myocardial infarction,594,679,12 months,10,1.4727540501
Medicare,TNF,Cardiac disease,Myocardial infarction,594,679,24 months,17,2.5036818851
Medicare,TNF,Cardiac disease,Myocardial infarction,594,679,36 months,22,3.2400589102
Medicare,TNF,Cardiac disease,Myocardial infarction,594,679,AS cohort entry to exposure,9,1.3254786451
Medicare,TNF,Infection,Hospitalized infection,594,679,12 months,67,9.8674521355
Medicare,TNF,Infection,Hospitalized infection,594,679,24 months,122,17.967599411
Medicare,TNF,Infection,Hospitalized infection,594,679,36 months,145,21.354933726
Medicare,TNF,Infection,Hospitalized infection,594,679,AS cohort entry to exposure,71,10.456553756
Medicare,TNF,Infection,Opportunistic infection,594,679,12 months,26,3.8291605302
Medicare,TNF,Infection,Opportunistic infection,594,679,24 months,36,5.3019145803
Medicare,TNF,Infection,Opportunistic infection,594,679,36 months,43,6.3328424153
Medicare,TNF,Infection,Opportunistic infection,594,679,AS cohort entry to exposure,29,4.2709867452
Medicare,TNF,Inflammatory bowel disease,Crohn’s Disease,594,679,12 months,45,6.6273932253
Medicare,TNF,Inflammatory bowel disease,Crohn’s Disease,594,679,24 months,48,7.0692194404
Medicare,TNF,Inflammatory bowel disease,Crohn’s Disease,594,679,36 months,48,7.0692194404
Medicare,TNF,Inflammatory bowel disease,Crohn’s Disease,594,679,AS cohort entry to exposure,39,5.7437407953
Medicare,TNF,Inflammatory bowel disease,Ulcerative Colitis,594,679,12 months,28,4.1237113402
Medicare,TNF,Inflammatory bowel disease,Ulcerative Colitis,594,679,24 months,35,5.1546391753
Medicare,TNF,Inflammatory bowel disease,Ulcerative Colitis,594,679,36 months,37,5.4491899853
Medicare,TNF,Inflammatory bowel disease,Ulcerative Colitis,594,679,AS cohort entry to exposure,28,4.1237113402
Medicare,TNF,Kidney disease,IgA nephropathy,594,679,12 months,1,0.147275405
Medicare,TNF,Kidney disease,IgA nephropathy,594,679,24 months,2,0.29455081
Medicare,TNF,Kidney disease,IgA nephropathy,594,679,36 months,3,0.441826215
Medicare,TNF,Kidney disease,IgA nephropathy,594,679,AS cohort entry to exposure,3,0.441826215
Medicare,TNF,Kidney disease,Nephrotic syndrome,594,679,12 months,1,0.147275405
Medicare,TNF,Kidney disease,Nephrotic syndrome,594,679,24 months,1,0.147275405
Medicare,TNF,Kidney disease,Nephrotic syndrome,594,679,36 months,1,0.147275405
Medicare,TNF,Kidney disease,Nephrotic syndrome,594,679,AS cohort entry to exposure,0,0
Medicare,TNF,Lung disease,Interstitial lung disease,594,679,12 months,4,0.58910162
Medicare,TNF,Lung disease,Interstitial lung disease,594,679,24 months,11,1.6200294551
Medicare,TNF,Lung disease,Interstitial lung disease,594,679,36 months,14,2.0618556701
Medicare,TNF,Lung disease,Interstitial lung disease,594,679,AS cohort entry to exposure,7,1.0309278351
Medicare,TNF,Lung disease,Restrictive lung disease ,594,679,12 months,29,4.2709867452
Medicare,TNF,Lung disease,Restrictive lung disease ,594,679,24 months,39,5.7437407953
Medicare,TNF,Lung disease,Restrictive lung disease ,594,679,36 months,47,6.9219440353
Medicare,TNF,Lung disease,Restrictive lung disease ,594,679,AS cohort entry to exposure,30,4.4182621502
Medicare,TNF,Neurological Disease,Cauda Equina syndrome,594,679,12 months,1,0.147275405
Medicare,TNF,Neurological Disease,Cauda Equina syndrome,594,679,24 months,1,0.147275405
Medicare,TNF,Neurological Disease,Cauda Equina syndrome,594,679,36 months,1,0.147275405
Medicare,TNF,Neurological Disease,Cauda Equina syndrome,594,679,AS cohort entry to exposure,1,0.147275405
Medicare,TNF,Neurological Disease,Spinal Cord compression,594,679,12 months,2,0.29455081
Medicare,TNF,Neurological Disease,Spinal Cord compression,594,679,24 months,2,0.29455081
Medicare,TNF,Neurological Disease,Spinal Cord compression,594,679,36 months,2,0.29455081
Medicare,TNF,Neurological Disease,Spinal Cord compression,594,679,AS cohort entry to exposure,1,0.147275405
Medicare,TNF,Osteoporotic fracture,Clinical vertebral fracture,594,679,12 months,28,4.1237113402
Medicare,TNF,Osteoporotic fracture,Clinical vertebral fracture,594,679,24 months,39,5.7437407953
Medicare,TNF,Osteoporotic fracture,Clinical vertebral fracture,594,679,36 months,45,6.6273932253
Medicare,TNF,Osteoporotic fracture,Clinical vertebral fracture,594,679,AS cohort entry to exposure,22,3.2400589102
Medicare,TNF,Osteoporotic fracture,Non-vertebral osteoporotic fracture,594,679,12 months,23,3.3873343152
Medicare,TNF,Osteoporotic fracture,Non-vertebral osteoporotic fracture,594,679,24 months,46,6.7746686303
Medicare,TNF,Osteoporotic fracture,Non-vertebral osteoporotic fracture,594,679,36 months,61,8.9837997054
Medicare,TNF,Osteoporotic fracture,Non-vertebral osteoporotic fracture,594,679,AS cohort entry to exposure,32,4.7128129602
Medicare,TNF,PsO/PsA,Psoriasis,594,679,12 months,47,6.9219440353
Medicare,TNF,PsO/PsA,Psoriasis,594,679,24 months,58,8.5419734904
Medicare,TNF,PsO/PsA,Psoriasis,594,679,36 months,63,9.2783505155
Medicare,TNF,PsO/PsA,Psoriasis,594,679,AS cohort entry to exposure,40,5.8910162003
Medicare,TNF,PsO/PsA,Psoriatic arthritis,594,679,12 months,76,11.192930781
Medicare,TNF,PsO/PsA,Psoriatic arthritis,594,679,24 months,85,12.518409426
Medicare,TNF,PsO/PsA,Psoriatic arthritis,594,679,36 months,87,12.812960236
Medicare,TNF,PsO/PsA,Psoriatic arthritis,594,679,AS cohort entry to exposure,70,10.309278351
Medicare,TNF,Uveitis,Uveitis,594,679,12 months,35,5.1546391753
Medicare,TNF,Uveitis,Uveitis,594,679,24 months,41,6.0382916053
Medicare,TNF,Uveitis,Uveitis,594,679,36 months,50,7.3637702504
Medicare,TNF,Uveitis,Uveitis,594,679,AS cohort entry to exposure,33,4.8600883652
